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N ovem ber 1973 EDITORIAL COMMENT 349
\  Q U I L L  O N  S C A L P E L  This section
provides a medium through which Canadian 
surgeons can declare themselves, briefly and in­
formally, on the day-to-day affairs of surgery.
PROPHYLACTIC ANTIBIOTICS
There are two sides to most stories. The 
case for the use of prophylactic antibiotic 
therapy in certain surgical situations was 
eloquently made in “Quill on Scalpel” May 
1973,1 but careful examination of the data 
could lead to very different conclusions 
from those reached in that contribution. 
The other side of the story should also be 
told in order that informed judgment may 
be made.
The recommendation was made that pro­
phylactic antibiotics should be administered 
in clean-contaminated cases (in which the 
gastrointestinal, respiratory, or genito­
urinary tract is entered without gross spil­
lage) and in contaminated cases (in which 
there is gross spillage or acute inflamma­
tion). The results of the randomized pro­
spective trials on which this recommendation 
was based require further examination.
In the series of Bernard and Cole,2 only 
118 patients were fully subjected to the 
randomized protocol. Of the 55 patients 
receiving prophylactic antibiotics, three de­
veloped infection, and of 63 patients re­
ceiving the placebo, 16 developed infection. 
Most of their patients had gastric or biliary 
tract operations, but we are not told which 
operations were followed by infection. This 
is of paramount importance. Clearly, some­
thing much more fundamental than antibiotic 
therapy is required in any surgical depart­
ment experiencing a 25% incidence of 
wound infection in gastric and biliary tract 
surgery. The results of Polk and Lopez- 
Mayor’s . study3 were quoted as further 
evidence of the value of prophylactic 
therapy. For colorectal operations their case 
was well made, but there must be a serious 
question regarding their criteria for “in­
fection”, for they state that the frequency 
of infection in the placebo group of gastro­
duodenal operations (11 out of 36 patients,
31%) was the same as in colorectal opera­
tions (15 out of 50, 30%).
It may be necessary to modify the defini­
tion of clean-contaminated cases as it is 
unreasonable to include uncomplicated 
gastric and biliary tract operations in the 
same group as colorectal operations. On 
the basis of this grouping, Dr. MacLean 
clearly advised that prophylactic antibiotics 
should be administered to all patients under­
going uncomplicated gastrectomy, pyloro­
plasty, or cholecystectomy, for example. 
In the large, comprehensive and detailed 
survey of postoperative wound infections 
reported by the National Academy of 
Sciences-National Research Council,4 sub­
total gastrectomy resulted in a wound infec­
tion rate of 10.1% (29 of 288) and un­
complicated cholecystectomy 6.9% (52 of 
756). There is another interesting way of 
looking at these statistics. Even if the high 
infection rate figure of, say, 10% is ac­
cepted for this type of operation, and if it is 
conceded that this may be reduced to 4% 
by prophylactic antibiotics, then we have 
given 100 patients antibiotic therapy in 
order that six may benefit. In discussing 
the related controversial topic of prophy­
lactic antibiotics in cesarean section, a 
recent editorial in the British Medical Jour­
nal5 pointed out that in the years 1967 to 
1969 there was an average of 41 maternal 
deaths associated with 35,000 sections an­
nually. Of these deaths, four were caused by 
sepsis. Whether or not prophylactic anti­
biotics should be given to 35,000 patients 
in an attempt to avert this disaster in four 
is a difficult question, and the answer is 
not immediately obvious. This kind of cost- 
benefit analysis is an invidious undertaking, 
but it is salutary, especially in view of the 
relatively minor role of antibiotics in the 
whole picture of bacterial attack and host 
resistance. Statistical significance is easier 
to prove than clinical importance and re-
350 THE CANADIAN JOURNAL OF SURGERY Vol. 16
levance. The* )^%ngers of antibiotics must not 
be treated liglftly, as is done in all the pub­
lications quoted purporting to show benefit 
from their use. The immediate problems 
of adverse drug reaction and detrimentally 
altered host bacterial flora are well known 
and measurable; the potential long-term ef­
fects on bacterial resistance and virulence 
are unknown and incalculable.
There has recently been a welcome return 
to saline irrigation for all wounds, and 
delayed primary skin closure for contam­
inated wounds. These techniques were also 
glossed over in the previous editorial.1 Saline 
irrigation has been practised by surgeons 
for more than half a century, although the 
reasons for its efficacy are only now better 
understood. The excellent monograph by 
Robson, Krizek and Heggers6 has brought 
together all aspects of the biology of sur­
gical infection, including the important role 
of the bacterial dose in relation to wound 
infection. Ten thousand organisms per gram 
of tissue or per millilitre of biologic fluid 
rarely produce infection, 107 almost in­
variably do. This critical bacterial dose of 
10° to 106 organisms per gram, which is 
necessary to produce infection, varies little 
for the different organisms studied. The 
role of saline irrigation before wound closure 
is therefore clear. The addition of antibiotic 
to the irrigating solution causes further re­
duction in the wound bacterial count, but 
some of the reservations discussed above are 
again relevant.
For clean-contaminated upper gastro­
intestinal and biliary tract wounds, and for 
clean wounds, delayed primary closure is 
obviously inappropriate as the risk of in­
fection is so low. For lower gastrointestinal 
tract wounds, and contaminated wounds, 
the use of this technique eliminates wound 
infection as a significant problem. Andersen, 
Korner and 0stergaardT performed primary 
closure in their entire series of colorectal
cases with no wound irrigation. They de­
monstrated reduction of wound infection 
with topical ampicillin (although this re­
duction was significant only in patients who 
did not have antibiotic intestinal prepara­
tion), but the following question is still 
relevant. Is it better to perform delayed 
closure and virtually eliminate wound in­
fection, or to practise primary closure and 
administer antibiotics to achieve almost 
as good results?
The other side of this highly controversial 
story has now been presented. The issue 
is not so straightforward as some recent 
articles have implied and no blanket re­
commendation for the use of prophylactic 
antibiotics is acceptable at this time.
C harles J. W right
Department of Surgery, 
University Hospital, 
Saskatoon, Sask.
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RE V IE W  A R TIC LE
HEART TRANSPLANTATION: 
CLINICAL AND EXPERIMENTAL PROGRESS*
e' i ^ el^  ’ F-R.C.S.[C], F.A.C,S.,t With the Assistance of 
M. H. MULLERWORTH, M.D., W. LIXFELD, D.V.M., M D SILVER M B 
K. H. SHUMAK, M.D., W. G. BIGELOW, M.D. and 
J. H. CROOKSTON, M.D., Toronto, Ont.
“ The only answer to these grim mo­
ments when great despair and at times 
real and severe anguish are felt is to 
have faith in our basic policy and deci­
sions. I do not mean that one should not 
seek out errors and adjust them, but 
tenacity of purpose is essential.”
Sir Russell Brock,1 1962
Of  the 189 patients throughout the 
world on whom a heart transplant had 
been performed only 29 were still alive 
on April 1, 1972.-‘8 However, this high 
early mortality must be analyzed in the 
perspective of a new operation that was 
performed within a short period in 
many different centres. Because it was 
not so analyzed the number of trans­
plants performed rapidly decreased and 
at the present time potential recipients 
die for want of such operations. This 
short-term view produced discourage­
ment among the public and within the 
medical profession and led, in turn, to 
a suspension of new work and a halt 
in real progress in cardiac transplanta­
tion. On the other hand, during the past 
few years a total of 159 liver trans­
plants have been performed and only 
nine recipients have survived with func­
tioning grafts. This high failure rate 
has not stirred the public conscience, 
nor did the early high failure rate of 
renal transplants a decade ago raise 
any public outcry.
’"From the Division of Cardiovascular Surgery, 
Toronto General Hospital, and the Departments’ 
of Surgery, Medicine and Pathology, Univer­
sity of Toronto, Toronto, Ont.
Supported by the Ontario Heart Foundation 
and the Medical Research Council of Canada. 
Presented to the International College of Sur­
geons, Manitoba Chapter, Winnipeg, Man.. 
April 22, 1972.
tAssistant Professor, Department of Surgery 
University of Toronto; Staff Surgeon, Division 
of Cardiovascular Surgery, Toronto General 
Hospital.
Sensational journalism has contribut­
ed markedly to public disillusionment 
in heart transplants and, in the wake 
of sharp disappointment following the 
poor survival experience, professional 
enthusiasm and research support have 
waned. Potential donor families are un- 
enthusiastic and our neurosurgical col­
leagues have largely withdrawn from a 
co-operative effort to provide donors. In 
addition, there is still a deep-seated re­
luctance to recognize that the heart is 
a donor organ like the kidney. This re­
sponse reflects not only the emotional 
significance of the organ but also our 
mythology, which equates the heart with 
the soul. Despite these difficulties, the 
public acceptance of the definition of 
“ neurological death” and the enactment 
in some provinces of definitive legisla­
tion concerning the disposal of bodies 
and organs have been significant steps 
forward.
At the Toronto General Hospital we 
have been actively involved in clinical 
and experimental research in cardiac 
transplantation for the past four years. 
There has been a multidisciplinary ap­
proach integrating the Departments of 
Surgery, Medicine and Pathology. This 
activity has included personal communi­
cation with, and numerous visits to, 
other centres with large transplant pro­
grams. Our experience indicates that, 
despite the dismal results so far report­
ed, in the overall outlook for human 
heart transplantation there is reason 
for optimism. Functional performance 
of the human cardiac allograft and re­
habilitation of the recipients have been 
gratifying. Human heart transplants 
are still being performed in many 
centres and patients have now survived 
into their third year. This paper will 
assess the current status of cardiac
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transplantation and review clinical and 
experimental progress in this field since 
December 1967.
Surgical Technique
The current operative technique has 
been successfully adapted from the 
classic experimental orthotopic model 
with but few modifications, notably ex­
tension of the inferior vena caval in­
cision to the right atrium to preserve 
donor sinoatrial conduction path­
ways.9- 10 Central cannulations avoid 
lymph fistulas, sepsis and arterial dis­
ruption in the inguinal area. Ligation 
of all four atrial appendages prevents 
thromboembolism.
Viable myocardium can be main­
tained by simple anoxic normothermic 
arrest if it does not last longer than 45 
minutes, although hypothermia and/ox- 
coronary perfusion may help to pre­
serve the functional integrity of the 
donor heart for a longer period. Perfu­
sion of the donor heart with electrolyte 
solutions until the coronary sinus efflu­
ent is clear may decrease the antigenic 
challenge of the transplant by washing 
out donor leukocytes.
Thymectomy is a simple procedure 
during median sternotomy and when 
added to standard immunosuppressive 
therapy may prolong allograft survival 
in animals. The use of leukocyte-poor 
blood in the extracorporeal circuit prime 
(or use of a “ no-blood” prime) may de­
crease the recipient’s sensitization by 
cross-reactive antigens which are pres­
ent on viable platelets and leukocytes.11
Preoperative management of the 
donor per se has been greatly improved. 
The ideal donor should be: young (15 
to 35 years), free of chest trauma and 
systemic bacteremia, without evidence 
of having taken excess sedation or of 
having attempted suicide. He should be 
kept in a warm, stable state; hypoten­
sion and acidosis should be avoided and 
prolonged vasopressor therapy should 
be withheld.1- Coronary angiography 
and cardiac catheterization may be ne­
cessary in the older donor, or when in­
trinsic heart disease is suspected in a
younger donor. Focal myocardial dam­
age and possible impairment of subse­
quent donor heart function have been 
reported when the donors had suffered 
prolonged increases in intracranial pres­
sure.13 Although much attention has 
been paid to size and sex discrepancies 
between the donor and l-ecipient, a 
small heart may be functionally ade­
quate for the larger recipient except 
during a rejection episode.
Recipient Selection
Developments in myocardial revascu­
larization have modified the selection 
of recipients to a considerable degree. 
Because the physician cannot predict 
the natural history of patients with ir­
reversibly scarred myocardium, it is 
difficult to assign “terminal” status ac­
curately before the onset of irreversible 
pulmonary, hepatic or renal failure. 
Most “ selected” recipients lived only 
one to three months if no donor became 
available.7
The pulmonary vascular resistance of 
the recipient should not exceed six units. 
Younger patients with complex congeni­
tal anomalies, e.g. truncus arteriosus, 
cannot be candidates for transplantation 
because severe pulmonary hypertension 
may compromise subsequent right ven­
tricular function. Medical disease that 
might be aggravated by immunosup­
pressive therapy, e.g. diabetes, or sui"- 
gical conditions that may complicate the 
postoperative course, e.g. cholelithiasis, 
are also contraindications to transplan­
tation.13- 14
Initial concern about early rejection 
of cardiac allografts by recipients with 
an established immune destructive pro­
cess, e.g. cardiomyopathy, or rheumatic 
heart disease, appears groundless be­
cause Kahn et alA5 have obtained pro­
longed survival in such patients. Indeed, 
patients with primary cardiomyopathy, 
excluding acute myocarditis, may be 
prime candidates because they are 
young and free of secondary organ dys­
function.
The importance of previous sensitiza­
tion of recipients through pregnancy,
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transfusions, open-heart surgery, cer­
tain infections or the presence of auto­
immune (anti-heart) antibodies, re­
mains speculative, but this mechanism 
may be responsible for accelerated re­
jection.
The ideal recipient for a heart trans­
plant is less than 50 years old, has mini­
mal cachexia, suffers from Class IV 
untreatable refractory heart disease, 
has minimal hepatic or renal insuffici­
ency and no active infection. Finally, 
he or she has a stable emotional state, 
strong family support and positive 
motivation.16
Immunosuppressive T herapy
Guidelines for immunosuppression 
have been derived from experience with 
renal transplants; azathioprine and 
prednisone remain the cornerstones of 
such therapy.17 The natural responsive­
ness of the cardiac recipient is higher 
than that of the kidney recipient and 
relatively high doses of immunosuppres­
sive drugs have been required to pre­
vent or treat rejection.6- 7 18 Cyclophos­
phamide or actinomycin D has been 
added during acute rejection. Intermit­
tent high-dose intravenous methylpred- 
nisolone appears to reverse acute rejec­
tion crises.17 The value of antilympho­
cyte globulin, graft irradiation and anti­
coagulants remains uncertain. Experi­
mental data suggest that anticoagulants 
alone can prolong allograft survival, 
and heparin has been used to prevent 
intravascular coagulation during acute 
rejection.10’ 20 As an immunosuppres­
sive measure, graft irradiation to pre­
vent rejection by “ killer” or sensitized 
lymphocytes perhaps deserves more con­
sideration than it has so far received.21 
After transplantation in the experimen­
tal animal, local irradiation alone re­
verses rejection.21' 22
There is no general agreement among 
transplant surgeons concerning the use 
of antilymphyocyte globulin because of 
the varied sources, potency, dosage 
schedules and concomitant administra­
tion of standard immunosuppressive
measures.23'25 However, the cardiac al­
lograft can survive for a long time 
without antilymphocyte globulin. We 
and others have demonstrated that anti­
lymphocyte globulin alone can prolong 
survival of experimental cardiac allo­
grafts by actions that affect cellular 
immune mechanisms primarily.26'28
Immunosuppressive therapy for acute 
rejection must be instituted early and 
must be vigorous because heart tissue is 
particularly susceptible to the residual 
damage that follows poorly controlled 
rejection. There is as yet no effective 
therapy for the endarterial lesions of 
chronic rejection, but it may be worth 
while to use agents that interfere with 
platelet aggregation or to administer 
long-term anticoagulants, combined 
with maintenance azathioprine.
In the future, biologic therapy with 
improved antilymphocyte sera, the ad­
ministration of solubilized antigens, 
antibodies or antibody-fragments or 
other immunologic manipulations may 
facilitate “ enhancement” or the induc­
tion of graft tolerance. For example, 
we have recently demonstrated im­
provement in the duration of cardiac 
allograft survival in mongrel dogs after 
administration of a multispecific crude 
immune serum.
The high incidence of infection (up 
to 60%) after heart transplantation is 
a major cause of morbidity and mortal­
ity.20 Pulmonary sepsis, the most com­
mon, occurs in almost 50% of patients 
and is considerably more common than 
in renal transplant recipients despite 
their more obvious endogenous sources 
of bacteria, e.g. repeated dialysis, geni­
tourinary infections, etc.12’ 20> 30 Ter­
minal cardiac patients have chronic pul­
monary congestion and pulmonary vas­
cular changes; patients with coronary 
occlusive disease are often heavy cigar­
ette smokers; pulmonary complications 
are common after perfusion, thoraco­
tomy and prolonged assisted ventilation. 
Despite a wide variety of predominantly 
exogenous and opportunistic organisms 
occurring in multiple sites, and the ne­
cessity for immunosuppression, aggres-
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sive management of infection after 
transplantation may be successful.
F unction  and  Survival
Immediate postoperative survival de­
pends upon: (a) preservation of the 
donor heart, (b) the operative proce­
dure, and (c) the status of the recipi­
ent’s other organ systems. Excluding 
the technical misadventures of earlier 
cases, rejection and sepsis continue to 
be the major causes of mortality after 
cardiac transplantation. Nevertheless, 
the Stanford University Transplant 
Service has now achieved a 50% one- 
year survival after a cumulative experi­
ence of 43 cases. The degree of physical 
and social rehabilitation achieved by 
the 16 long-term survivors has been 
very gratifying.13' 31- 32
The performance of the transplanted 
heart is usually satisfactory; exercise 
testing reveals that the recipients can 
sustain moderately strenuous work­
loads. Resting cardiac output and intra­
cardiac pressures are normal but the 
cardiac index is slightly decreased. The 
denervated heart relies on intrinsic 
mechanisms to determine output and 
resting pulse rates are relatively high. 
On exercise, cardiac output increases 
primarily by increased stroke-volume; 
heart rate increases later from circulat­
ing catecholamines. Lymphatic ablation 
appears to have no effect on ventricular 
distensibility, but the damage inflicted 
during acute or chronic rejection may 
impair compliance and elevate end- 
diastolic pressures. Elevation of pul­
monary artery or left ventricular end- 
diastolic pressure on exercise may re­
flect previous pulmonary vascular 
changes, residual myocardial damage 
from organ transfer, the rejection pro­
cess, or the functional limitations of the 
catecholamine-depleted myocardium. 
There has been no clinical evidence of 
autonomic regeneration in the trans­
plant as shown by reflex physiologic and 
pharmacologic studies despite experi­
mental evidence of reinnervation, and 
the transplanted heart remains exquis­
itely sensitive to inotropic agents. Final­
ly, late coronary occlusive lesions may 
ultimately limit cardiac performance 
by precipitating ischemia or rhythm 
disturbances.5- "• 33-36
H istocompatibility Matching
The precise contribution of tissue 
typing to clinical heart transplantation 
remains uncertain. The value of leuko­
cyte antigen matching has been restrict­
ed by the limited availability of test 
antisera and has been complicated by a 
variety of test panels and the confusing 
nomenclature. Certainly many new spe­
cificities will be added to the HL-A 
locus, as currently defined. The rela­
tive strength of recognized leukocyte 
antigens in provoking rejection is not 
yet fully known; some antigens may be 
difficult to detect on certain lympho­
cytes, and the blood of donors with se­
vere intracranial injuries often contains 
a high percentage of damaged lympho­
cytes. Some antigens may be present on 
the heart in greater concentrations than 
on the test leukocytes. Thus, as in cada­
veric renal transplantation, some “good” 
matches have provoked early violent re­
jection, while some “poor” matches 
have been associated with prolonged 
survival. Hence, predicting survival on 
a matching grade of A to F tends to 
“ over-stylize” our present knowledge, 
e.g. many patients showing D matches 
have done quite well.37 To achieve clin­
ical compatibility, the surgeon must 
establish a balance between the anti­
genic disparity of donor and recipient, 
that is the degree of histoincompatibil- 
ity, and the efficacy of current immuno­
suppressive therapy at his disposal.
Although the immune response that 
provokes acute rejection is ultimately 
an expression of genetic disparity, the 
characteristics of the organ donated and 
the state of sensitivity of the recipient 
also make important contributions. The 
heart appears to be no less antigenic 
(i.e. immunogenic) than other tissues 
merely because it is a simple functional 
unit. This organ is as richly endowed 
with endothelial surfaces as the kidney, 
and therefore myocardium is just as
-1
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vulnerable to the vascular damage of 
the immune mechanism. Heart recipi­
ents do not have the diminished im­
munologic competence of the uremic 
patient nor do they usually receive sig­
nificant amounts of immunosuppressive 
therapy before transplantation.3 8 Fur­
thermore, because of a relatively high 
concentration of demonstrable lympho- 
cytotoxic antibodies in pre-transplant 
sera, cardiac recipients may be immuno- 
logically primed to mount an initial vig­
orous response.11’ 39
Early reports suggested that the 
length and quality of recipient survival 
after cardiac allografts correlate di­
rectly with the closeness of histocom­
patibility match.6' s' 40’ 41 The heart, 
instead of being an “ immunologically 
privileged” organ appeared subject to 
inexorably progressive rejection in pa­
tients with a poor match. In Cooley’s 
recipients, the average survival for B, 
C+, C— and D matches (Terasaki 
grading) was 74, 47.25, 42 and 11.5 
days respectively.8- 13 The Montreal ex­
perience demonstrated longer survival 
for A, B + and B matches (Van Rood) 
— 106, 38.2 and 120 days, than for C 
and D matches—68, 47, 64, 11 and two 
days.15 Terasaki confirmed this trend 
towards a clinical correlation.40 Experi­
mentally, the survival of cardiac trans­
plants for good DL-A matches in the 
closely bred Cooperstown beagle colony 
supports these clinical reports.42
None the less, the experience of the 
Stanford University team over a four- 
year period contradicts some of these 
assumptions. Stinson noted no signifi­
cant relationship between the number 
of mismatches and postoperative sur­
vival, rejection history, or clinical 
status.4- 5’ 43 Similarly, Lower et al.21 
suggested that leukocyte typing corre­
lated poorly with the frequency and 
severity of acute rejection, but they be­
lieve that such typing may help to avoid 
late loss of grafts from chronic rejec­
tion. In the Stanford series, HL-A mis­
matching did not preclude long-term 
survival with satisfactory graft func­
tion. Three out of four recipients living 
more than two years had mismatches
for all four antigens. There seemed to 
be no difference in either early or late 
survival in terms of the number of mis­
matches, or in relation to any particular 
antigen or combination of antigenic 
mismatches.43 It is difficult to learn 
whether these “poor” matches with pro­
longed survival required more, and more 
carefully administered, immunosuppres­
sive therapy. In the future, a larger se­
ries may demonstrate correlation be­
tween tissue typing and rejection, and 
the present lack of correlation may be 
due simply to the early detection of 
rejection and the blunting of incompat­
ibility by effective immunosuppressive 
treatment.44
At the present time, if the donor- 
recipient pair are ABO identical or com­
patible, and the cross-match between 
recipient serum and donor lymphocytes 
is negative for pre-formed antibodies, 
i.e. sensitization to donor antigen, 
transplantation should proceed regard­
less of the tissue-typing grade.
IMMUNOPATHOLOGY
Cell-mediated immune mechanisms 
are primarily responsible for cardiac 
allograft rejection and the pathologic 
process has been described in detail in 
numerous reviews.45'49 Cellular expres­
sion of the immune response depends on 
the timing, nature and duration of allo­
graft rejection and the degree to which 
this response is modified by immuno­
suppressive therapy. Considerable evi­
dence suggests that humoral antibodies 
also participate in the events that 
result in graft destruction.
“ Acute” cardiac rejection is charact­
erized by diffuse interstitial mononu­
clear-cell infiltration, perivascular and 
intimal lymphocyte aggregation, exuda­
tion of serum, fibrin and erythrocytes 
from damaged capillary endothelium, 
and foci of myocytolysis and myocardial 
necrosis.
“ Accelerated” rejection of human car­
diac allografts has been reported in re­
cipients with undetected preoperative 
sensitization to donor antigens.50’ 51 
Despite vigorous therapy, these hearts 
developed massive interstitial edema,
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hemorrhage, extensive infiltration with 
polymorphonuclear cells and necrosis of 
small arterial vessels and myocardial 
cells. Multiple venous and capillary oc­
clusions by fibrin thrombi or platelet 
aggregates were also noted. This “accel­
erated” rejection may represent hyper­
acute rejection modified by immuno­
suppression.
Truly “hyperacute” rejection (i.e. 
within a few minutes to a few hours), 
was observed in experimental animals 
sensitized by previous allografts and 
there was a close correlation between 
the recipient lymphocytotoxic titre and 
subsequent allograft destruction. After 
initial vigorous cardiac action, cyanosis, 
turgor, distension and ineffective con­
tractions developed rapidly in the trans­
plant. These changes were accompanied 
by massive edema, interstitial hemor­
rhage and capillary occlusion by plate­
let clumps, but without polymorphonu­
clear infiltration.r'-
“Chronic” rejection of cardiac allo­
grafts is characterized by destructive 
arteritis, intimal hyperplasia and fibro­
sis, subsequent narrowing of the coron­
ary arterial lumina and evidence of 
myocardial ischemia. Atherosclerotic 
changes have been noted in the thick­
ened vessels."’3 Accelerated atheroscler­
osis may represent the donor heart’s 
initial status or the recipient’s basic 
lipid abnormality, rather than any ef­
fect of chronic rejection. However, some 
correlation has been noted between ab­
normal lipid metabolism in the recipient 
and the number of acute rejection epi­
sodes, and subsequent coronary artery 
disease in the graft.
In the heterotopic transplant model, 
we and others have demonstrated the 
presence of lymphocytotoxic, anti-ery- 
throcyte and “heart-reactive” antibod­
ies in the serum, on the sarcolemma 
and in eluates recovered from the re­
jected heart. 3 4 ' 37 In clinical trans­
plants, bound immunoglobulin has been 
observed in large mononuclear cells, 
within myocardial fibres and on sar- 
colemmal membranes, confirming that 
antibody is absorbed by large organ 
grafts . 3 8  Circulating “heart-reactive”
antibody was demonstrated by in­
direct immunofluorescence in the
serum of human recipients; re­
trospective analysis showed good corre­
lation between detectable antibody and 
subsequent episodes of cardiac rejec­
tion. 38  Lymphocytotoxic antibodies have 
also been demonstrated in the sera of 
patients who died of infection or who 
ultimately succumbed after repeated 
episodes of allograft rejection. 39
Humoral antibody does participate 
in the immunologic response to allo­
grafted cardiac tissue. 38  Early vigorous 
graft destruction appears related to pre­
vious sensitization. The correlation be­
tween intimal fibroplasia and intimal 
lamellar immunoglobulin deposits seen 
in late deaths may indicate that anti­
body plays a role in chronic rejection. 
Since azathioprine and prednisone clear­
ly decreased the frequency of serum 
and sarcolemmal-bound antibodies in 
experimental transplants, combined 
maintenance therapy may prevent late 
coronary vascular changes. 34
D iagnosis of Cardiac Rejection
The clinical diagnosis of cardiac re­
jection can be made early, thus allowing 
for appropriately timed, intermittent 
high-dose therapy; early intervention 
may not only reverse rejection, but may 
minimize residual myocardial damage 
and reduce infectious complications. 20 
Acute cardiac rejection is episodic, oc­
curring most often and most severely 
in the first two to three months after 
transplantation. During this period the 
transplant team should maintain close 
surveillance of graft performance and 
host responses to anticipate rejection 
and institute early treatment.
Initially the criteria for the diagnosis 
of rejection were quite non-specific and 
the symptoms and signs were difficult 
to differentiate from other postopera­
tive phenomena. Among these, various 
workers have described the appearance 
of a pericardial friction rub, the onset 
of malaise, anorexia, nausea, aching, 
fever, tachycardia, cardiomegaly, hepa­
tomegaly and peripheral edema.20- 39 
Changes in graft function are subtle
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and reflect the histopathologic sequence 
and subsequent effect on myocardial 
performance;20- 60 interstitial edema 
and vascular congestion produce a 
thickened, less compliant myocardium. 
Most early signs of rejection reflect sim­
ply the inability of the thin right ven­
tricle to tolerate altered distensibility, 
particularly if it is already burdened by 
pre-existent pulmonary hypertension.
The earliest detectable electrocardio­
graphic findings include: decrease in 
the average QRS voltage—the sum 
of leads I, II, III, V. and V8—ST depres­
sion, T-wave inversion, significant axis 
shift and phonocardiographic demon­
stration of early gallop rhythms.20- 01 
Arrhythmias may reflect involvement 
of conduction pathways. Ultrasound 
echocardiography reveals increased 
ventricular-wall thickness or ventricu­
lar diameter;22- 62 ballistocardiography 
may demonstrate decreased contractile 
force;63 indirect arterial pulse meas­
urements may show decreased systolic 
impulse and decreased dp/dt. Clinical 
findings reflect chiefly myocardial re­
striction and low output, viz. diastolic 
gallop, decreased precordial impulse, 
right ventricular lift, hypotension, etc.
Biochemical indices of rejection have 
not been as precise, reliable or prognos­
tic as originally suggested. According to 
Nora,6- 04 specific patterns of abnor­
mality of lactic dehydrogenase isoen­
zymes, fractions 1 and 2, total lactic 
dehydrogenase, creatinine phosphokin- 
ase and serum glutamic oxaloacetic 
transaminase are “diagnostic”— an in­
dex of rejection in the first month after 
transplant, when the electrocardiogram 
may be least reliable. Serum enzymes 
of myocardial origin are elevated in 
cardiac rejection, but such rises usually 
only confirm clinical findings and re­
flect established myocardial cellular 
damage.65 Chronic rejection may be 
diagnosed by the ischemic patterns on 
cardiography, late conduction disturb­
ances, coronary angiography or radio­
active scans, which reflect impaired my­
ocardial blood flow.66
Monitoring immune responses of the 
recipient may confirm clinical suspi­
cions of graft rejection most precisely. 
The appearance of lymphocytotoxic an­
tibody in recipient serum may only re­
flect the presence of cross-reacting an­
tigenic stimuli (bacteria, transfusions) 
or may indicate established rejection, 
antibody appearing in serum only after 
antigen sites on the rejecting organ are 
saturated. Detection of “heart-binding” 
antibody in serum may be an early and 
reliable test for impending rejection.67 
Inhibition of capillary leukocyte migra­
tion, as described by Falk et al.es pro­
vides a rapid and reproducible means of 
measuring the development of cell-me­
diated immunity. This test can be used 
to monitor the development of immu­
nity in renal transplant recipients and 
may predict rejection before significant 
target-organ damage develops.
Conclusion
For well-selected patients with ter­
minal heart disease, cardiac transplan­
tation is technically feasible, morally 
acceptable and provides good palliation. 
Blood-group compatibility and a nega­
tive cross-match between donor tissue 
and recipient serum appear to be the 
only significant immunologic consider­
ations at present. However, it should 
not be considered that leukocyte-anti­
gen matching, in its present form, is of 
no value, because graft survival with 
function may correlate better with tis­
sue typing when larger recipient pools 
are created, donors are more readily 
available, and more detailed knowledge 
is obtained concerning the genetic ex­
pression of histocompatibility antigens. 
Mechanical circulatory assistance and 
improved organ preservation may also 
contribute to better donor-recipient 
matches.
Clinically, cardiac rejection can be 
recognized early and residual myocar­
dial damage can be prevented by re­
versing rejection with current immuno­
suppressive agents. Monitoring host re­
sponsiveness to the allograft may be 
useful in predicting rejection, but con­
siderably more time, effort and money 
must be invested in both human and 
experimental transplants to validate
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the presently available laboratory tech­niques.The full potential of cardiac trans­plantation will only be realized when clinical and immunologic efforts are in­tegrated. Functional performance of the human cardiac allograft has been eminently satisfactory. Therefore heart transplantation in a clinical setting should be continued at selected centres as an investigative, and occasionally therapeutic, procedure.
The author wishes to thank Drs. J. 0. 
Godden and W. G. Bigelow for their consider­
able advice during the preparation of this 
paper.
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progressive 
pulmonary failure: 
a critical consequence 
of shock
The recovery of patients in shock is often complicated by a pattern of de­
teriorating pulmonary function commonly described as “ shock lung.” Despite 
the restoration of haemodynamic balance and apparent stabilization of the 
acute episode, many patients develop progressive pulmonary insufficiency, 
characterized by vascular congestion, haemorrhage into the interstitium and 
alveoli, and pulmonary oedema, both interstitial and intra-alveolar.
These disruptions begin at the cellular level where lack of oxygen causes 
alterations in the oxygen-carbon dioxide exchange mechanism. The changes 
in cell metabolism lead ultimately to interstitial oedema and perivascular 
haemorrhage.1 Polymorphonuclear leukocytes aggregate in the pulmonary 
capillaries obstructing the pulmonary vascular bed. As the trapped cells 
break down, they release lysosomes, tiny subcellular particles containing 
proteolytic enzymes.1 These enzymes attack their host cell and go on to 
damage or destroy other cells.2 The resulting tissue damage may not readily 
repair itself even if the shock patient survives.
protective effects 
of corticosteroids
The key to increased survival in shock, therefore, may lie in protecting the 
pulmonary architecture through preservation of the cell. If cellular integrity 
can be maintained, the progress of pulmonary destruction may be halted 
or reversed.
Current studies indicate that massive doses of corticosteroids can effectively 
alleviate these cellular changes if administered early in the course of the 
pulmonary insult. Corticosteroids appear to minimize tissue damage and 
preserve organ function by stabilizing cellular and lysosomal membranes 
thereby preventing the release of lysosomal enzymes.3
A^.
In treating severe shock, there is a tendency in current 
medical practice to use massive (pharmacologic) 
doses of corticosteroids. (The anti-inflammatory activity 
of 1 mg of Solu-Medrol is equal to 4 mg or more of 
hydrocortisone.)
The suggested dosage of Solu-Medrol for severe shock 
is 30 m g/kg stat and repeated in four hours, if necessary. 
Therapy is in itiated by administering Solu-Medrol 
intravenously over a period of one to several minutes.
In general, therapy should be continued only until 
the patient’s condition has stabilized -  usually not 
beyond 48 to 72 hours.
Solu-Medrol may be given by intravenous injection, 
by intravenous infusion, or by intramuscular in jection. 
The preferred method for in itia l emergency use is 
intravenous injection.
Cautions: The general precautions and contraindications 
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the use of Solu-Medrol. However, when used for medical 
emergencies, or in shock-like states, the possible
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Solu-Medrol should be adjunctive to conventional 
supportive therapy such as flu id  replacement, etc. 
Although adverse effects associated with high-dose 
short-term co rtico id  therapy are uncommon, peptic 
ulceration may occur.
Supplied: In Mix-O-Vials containing Medrol (as 
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DISTRIBUTION OF CARDIAC OUTPUT IN UNANESTHETIZED RATS 
AFTER HEMORRHAGE AND IN HEMORRHAGIC SHOCK*
K. RAKUSAN, M.D., Ph.D. and J. RAJHATHY,
Ottawa, Ont.
Summary: Experimental hemorrhagic shock was 
induced by removing 40% of the total blood 
volume in unanesthetized rats. Major redistribu­
tion of the cardiac output occurred immediately 
after the blood removal, the most important 
change being the increase in the coronary and 
bronchial fractions, mainly at the expense of the 
renal and skin fractions. In the animals surviving 
the hemorrhagic shock, distribution of the cardiac 
output tends to return to normal, preserving the 
moderately increased coronary and liver frac­
tions. Cardiac output distribution in dying animals 
resembled that after the blood removal; the 
differences from normal were even more pro­
nounced.
Resume: Les chercheurs ont provoque un choc 
hemorragique experimental chez des rats non 
anesthesies en enlevant 40% du total du volume 
sanguin. Une nouvelle distribution du debit 
cardiaque est survenue immediatement apres la 
spoliation sanguine, le changement le plus im­
portant etant une augmentation du debit au 
niveau des coronaires et des bronches, princi- 
palement aux depens des fractions renales et 
cutanees. Chez les animaux qui ont survecu au 
choc hemorragique, la distribution du debit 
cardiaque a presente une tendance a la norma­
lisation, tout en sauvegardant les fractions coro­
naires et hepatiques. La distribution du debit 
cardiaque chez les animaux moribonds ressem- 
blait a celle qu'on constatait apres I'hemorragie: 
les ecarts de la normale etaient meme plus 
prononces.
D e s p it e  the extensive literature describ­
ing the effect of hemorrhage on the re­
gional distribution of cardiac output, 
the results of the investigations re­
ported are far from conclusive. While 
some variations in reported results 
are to be expected among different 
animal species, many apparent contra­
dictions are due to differences in meth­
ods by which experimental shock has 
been produced and to the use of anes­
thesia. In 1956 Sapirstein1 proposed the
*From the Department of Physiology, Faculty 
of Medicine, University of Ottawa, Ottawa, 
Ont.
Supported by the Medical Research Council of 
Canada.
rubidium method for measurement of 
distribution of cardiac output. This 
method has been applied in studies on 
hemorrhage by several authors, includ­
ing Sapirstein himself.2"3 We have re­
peated these experiments for two rea­
sons. First, most of the previous studies 
were done on anesthetized animals. Un­
der anesthesia the level of circulating 
catecholamines may be increased, myo­
cardial contractility is decreased and au­
tonomic control may be impaired at all 
levels. For instance, Neutze, Wyler and 
Rudolph0 reported significant differ­
ences in the distribution of cardiac out­
put in anesthetized and unanesthetized 
rabbits. Therefore the reaction of ani­
mals to anesthesia itself may influence 
their response to hemorrhage. Second, 
most of the researchers in the field use 
the classical Wigger’s model for hemor­
rhagic shock in which the animals are 
bled into a reservoir with a constant 
blood pressure. This model has been 
criticized since it induces constant hypo­
tension rather than hemorrhagic 
shock.7' 8 Blood loss immediately results 
in homeostatic mechanisms which tend 
to restore the arterial pressure while 
the experimental technique proposed by 
Wiggers continuously defeats this re­
adjustment. Our study is concerned with 
flow readjustments which occur as a 
result of hemorrhage when such homeo­
static mechanisms are permitted to op­
erate. Hence we decided to use the model 
based on the withdrawal of a constant 
fraction of the total blood volume in 
unanesthetized rats.
M eth o d s
Model of Hemorrhagic Shock
This model is similar to that proposed 
by Ehrlich, Kramer and Watkins.8 
Sprague-Dawley male rats of an aver­
age body weight of 450 g. were used.
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Plastic cannulas (P'E 50) were insert­
ed into the right atrium via the jugular 
vein and into the aorta via the carotid 
artery in pentobarbital-anesthetized 
rats on the day before sacrifice. Simul­
taneously the total plasma volume was 
determined by standard dilution method 
using albumin-12 5I. The total blood vol­
ume was then calculated after correction 
of hematocrit for plasma trapping and 
taking into account the ratio of total 
body hematocrit to the blood hemato­
crit.0 The rats were fasted overnight 
and the experiment itself was per­
formed on unanesthetized animals.
On the day of the experiment the 
original blood pressure in the aorta was 
recorded on the Grass polygraph. After­
wards the rats were bled spontaneously 
via the aortic cannula. The amount of 
blood removed represented 40% of the 
total blood volume measured the day 
before the experiment. The time of 
bleeding was approximately 30 minutes.
Fig. 1.—Median values of the arterial blood 
pressure in 13 rats after removal of 40% of 
the total blood volume.
After the bleeding the rats were recon­
nected to the polygraph and the mean 
arterial pressure was recorded. Changes 
of the blood pressure in the preliminary 
experiment on 13 rats under the same 
experimental conditions are depicted 
in Fig. 1. Mean arterial pressure de­
creases to approximately 40 mm. Hg 
immediately after the blood removal; 
it then rises and remains stable in the 
range of 50 to 80 mm. Hg. After a vari­
able length of time, a second rapid de­
crease in the blood pressure occurs and 
the animal dies. The mortality six hours 
after the blood removal is close to 50% 
(i.e. seven rats out of 13 died).
In the present experiment regional
distribution of cardiac output was 
measured immediately after the blood 
removal (nine rats), at the period 
of “ stabilized” hypotension three hours 
after the blood removal (13 animals) 
and at the second decline of the blood 
pressure (12 “dying” rats). The results 
were compared with those in normal 
rats of the same strain and body weight 
(nine control animals). The definition 
of “dying” animals is based on the pre­
liminary study mentioned above in 
which all animals with a second rapid 
decline in the mean arterial blood pres­
sure died. Rubidium-86 was injected 
when the blood pressure declined to 20 
mm. Hg, irrespective of the time inter­
val after the blood removal.
Distribution of Cardiac Output
The fractional distribution of cardiac 
output was measured by the indicator 
fractionation technique with 86Rb.1' 10 
This technique is based upon the as­
sumption that all tissues will show 
similar fractionation of the isotope if 
their blood flow rates are equal. This 
assumption is valid for all organs ex­
cept the brain. Hence the 80Rb uptake 
by an organ will be related to total body 
uptake as is that organ’s blood flow to 
cardiac output.
Approximately 2 to 3 p.Ci of 8cRb 
(rubidium chloride) in 0.3 ml. of saline 
was injected into the right atrium via 
the implanted cannula and the cannula 
was flushed with saline. The animals 
were killed 60 seconds later by an in­
jection of saturated KC1 through the 
same cannula. The tissues were re­
moved, weighed and dissolved in 2N 
KOH (5N KOH in the case of carcass). 
Their radioactivity was determined in 
a Packard well counter. The results are 
expressed as fractional 80Rb uptake per 
organ.
All results were statistically analyzed 
by Student’s t test.
R e s u l t s
Average blood volume in our animals 
was 6.0 ±  0.2 ml./100 g. body weight; 
the average time of spontaneous bleed-
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TABLE I.—Percentage of S6Rb Uptake per Organ
Group Heart Lungs Liver Spleen Kidney GIT Testes Skin Carcass
ANormal animals. .. (9 rats)
2.2 ±  .2 1.5zt .1 8.2 ±  .7 .59±.05 20.7 ±  1.2 7.1 ±  .4 .24±.01 9.7 ±  .5 49.4 ±  1.6
BImmediately afterblood loss................(9 rats)
6.3±1.6 5.0±1.4 10.1 ±  1.6 .41±.11 11.8 ±  2.4 7.8 ±  .8 .36±.03 5.6 ±  .5 52.3 ±  2.1
CSurvivors.after 3 hrs..............(13 rats)
2.9 ±  .2 1.9 ±  .2 10.1 ±  .4 .50±.05 18.2 ±  .9 9.4 ±  .6 .15±.01 8.7 ±  .5 48.0 ±  1.1
DDying animals.......(12 rats) 8.8±1.4 3.3 ±  .6 7.2 ±  .9 .19±.06 8.6±  2.0 6.9 ±  .4 .16±.03 5.1 ±  .6 55.6 ±  2.0
Average values ±  standard error of the mean. GIT
ing was 35 minutes. Changes in the mean arterial blood pressure after the removal of 40% of the total blood vol­ume in the experimental groups were similar to those in the preliminary group under the same experimental con­ditions (see Fig. 1). Regional distribu­tion of the cardiac output was measured in nine rats immediately after the blood removal, in 13 rats which survived three hours of hemorrhagic shock and in 12 “dying” rats irrespective of time inter­val after the blood removal. The sur­vival of rats was related neither to their
= gastrointestinal tract.
original blood volume nor to the time of spontaneous bleeding.The results are expressed as percent­age of 86Rb uptake per organ which corresponds to the percentage of car­diac output. They are summarized in Tables I and II. Table III shows the same results computed per gram of tis­sue in order to compare relative organ flows. Changes in this index display a similar pattern and they are not dis­cussed separately. In addition to the re­sults included in Tables I to III, the val­ues for the heart and gastrointestinal
TABLE II.—Statistical Significance of the D ifferences in the Regional D istribution of 86R bUptake (P Values)
Groups B, C, D as compared with control group A Heart Lungs Liver Spleen Kidney GIT Testes Skin Carcass
Immediately after blood loss (B ).. <.05 <.05 NS NS <.01 NS <.001 <.001 NSSurvivors after 3hrs. (C )...............“Dying” animals(D ).......................
<.05 NS <.05 NS NS <.01 <.001 NS NS
<.001 <.001 NS <.001 <.001 NS <.05 <.001 <.05
Groups C and D as compared with Group BSurvivors after 3 hrs. (C)............... <.05 <.05 NS NS <.001 NS <.001 <.001 <.05Dying animals (D) NS NS NS NS NS NS <.001 NS NS
Group C as com­pared with Group D Survivors after 3 hrs. (C)................... <.001 <.001 <.001 <.001 <.001 <.001 NS <.001 <.001
GIT = gastrointestinal tract, NS = not significant.
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tract were analyzed in more detail as 
right ventricle, left ventricle and sep­
tum in the case of heart and as stomach, 
small intestine and large intestine in the 
case of gastrointestinal tract. Changes 
in these individual portions displayed 
the same pattern. Therefore only the 
summarized values per total heart and 
gastrointestinal tract are reported.
Changes in Regional Distribution of 
Cardiac Output in Rats Dying 
From Hemorrhagic Shock
Values of the cardiac output fractions 
in these rats resemble those in rats im­
mediately after the blood removal; the 
differences from normal values, how­
ever, are more pronounced. There is a
TABLE III.— Percentage of 86Rb Uptake per Gram of T issue
Group Heart Lungs Liver Spleen Kidney GIT Testes Skin Carcass
A
Normal animals.. .  
(9 rats)
1.S6 
±  .14
O.SO 
±  .07
0.51 
±  .07
0.73 
±  .05
5.37 
±  .28
0.78 
±  .04
0.07 
±  .00
0.12 
±  .01
0.16 
±  .01
B
Immediately[after
blood loss............
(9 rats)
6.24
±1.57
3.02 
±  .90
0.95 
±  .16
0.62 
±  .18
3.68 
±  .78
0.95 
±  .10
0.13 
±  .01
0.07 
±  .01
0.18 
±  .01
C
Survivors after 
3 hrs.....................
(13 rats)
3.05 
±  .19
1.13 
±  .10
0.93 
±  .04
0.81 
±  0.5
5.29 
±  .28
1.13
±  ,0b
0.05 
±  .00
0.12 
±  .01
0.17 
±  .01
D
Dying animals.......
(12 rats)
8.77
±1.43
3.31 
=fc .62
0.53 
±  .06
0.25 
±  .08
2.62 
±  .60
0.85 
±  .06
0.05 
±  .01
0.07 
±  .01
0.20 
±  .01
Average values ±  standard error of the mean. GIT =  gastrointestinal tract.
Changes in Regional Distribution of 
Cardiac Output in Rats Immediately 
After Blood Removal
Significant increases in the coronary, 
bronchial and testicular fractions were 
found together with a non-significant 
increase in the carcass fraction. They 
were balanced by significant decreases 
in the renal and skin fractions.
Changes in Regional Distribution of 
Cardiac Output in Rats Surviving 
Three Hours of Hemorrhagic Shock
Values of the cardiac output fractions 
in these rats tend to return to normal. 
The animals, however, still differ from 
control rats by significantly higher cor­
onary, liver and gastrointestinal frac­
tions, together with a significant de­
crease in the testicular fraction and a 
non-significant decrease in the carcass 
fraction.
significant increase in the coronary, 
bronchial and carcass fractions together 
with a significant decrease in the renal, 
splenic, skin and testicular fractions. 
If one compares these rats with animals 
which survived three hours of hemor­
rhagic shock, the same differences as 
described above are apparent. These dif­
ferences, however, are even more pro­
nounced and reach a high level of statis­
tical significance (P <0.001). In addi­
tion, dying rats differ from survivors 
by significant decreases in the liver and 
gastrointestinal fractions.
D is c u s s io n
Our results concerning the total blood 
volume in rats before hemorrhage are 
well within the range of the values re­
ported in the literature previously.9' 11 
The values of the cardiac output distri­
bution in normal animals vary consider­
ably according to individual authors,
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m ethods and species. In addition, the  
older studies were done on anesthetized 
anim als in which the d istribution is in­
fluenced by the anesthesia itself. Our re ­
sults a re  com parable to the data of 
Stevens on unanesthetized ra ts .12
I t  should be noted that isotope uptake 
by the lungs corresponds to the bron­
chial blood flow and the isotope uptake 
by the liver corresponds to the hepatic 
a rte ria l blood flow.
In our experim ents, changes found in 
the regional distribution of cardiac out­
put a f te r  the hem orrhage are sim ilar to 
those reported  previously.2"3 1316 There 
is a general agreem ent th a t the immedi­
a te  response is characterized by an in ­
creased coronary and bronchial fra c ­
tion accompanied by a decreased fra c ­
tion of cardiac output to the kidneys 
and skin. These results are  also in agree­
m ent w ith  clinical observations under 
sim ilar conditions.17 In addition, in 
some cases a decreased fraction  of car­
diac output to the gastro intestinal tra c t 
and spleen has also been reported, to­
gether w ith an increased liver fra c ­
tion .2- 11 16 On the o ther hand, several 
au tho rs w ere unable to confirm  these 
additional find ings.3- 4- 16
The changes in the regional d istribu­
tion of the cardiac output in ra ts  su r­
viving th ree  hours of hem orrhagic 
shock or dying from hem orrhagic shock 
th a t are presented above are  difficult 
to com pare w ith the results reported in 
the lite ra tu re  because of the unique ex­
perim ental procedure. Com paring these 
two experim ental groups, it  m ay be 
seen th a t the  regional distribution of 
cardiac output in surviving ra ts  tends 
to re tu rn  to normal values while in 
victim s of hem orrhagic shock these val­
ues resem ble amplified changes imme­
diately a fte r  the hem orrhage. The su r­
viving ra ts , however, d iffer from  nor­
mal anim als in having significantly  
h igher coronary and liver fractions a t 
the  expense of slightly lower fractions 
of cardiac output in carcass, skin, kid­
neys and spleen. If one compares the 
ra ts  th a t  survived th ree  hours of hem ­
orrhagic  shock with the anim als th a t
w ere dying during the hem orrhagic 
shock, considerable changes in the dis­
tribu tion  of cardiac output to all m ajor 
organs are apparent. In  our opinion the 
m ost im portan t alterations are  a de­
creased fraction of the cardiac output 
to the splanchnic region and an in­
creased fraction  which supplies carcass. 
Ischem ia of the splanchnic region is 
probably responsible for the form ation 
of a myocardial depressant factor. Myo­
cardial depressant factor in tu rn  acts 
on an already weakened m yocardium  to 
promote cardiovascular collapse in 
shock as postulated by L efer.18 The 
second im portan t difference is an in­
crease in carcass fraction which reflects 
vasodilation in the periphery, m ainly in 
the vascular bed of the skeletal muscle, 
and which is directly responsible fo r 
the term inal decrease of the arteria l 
blood pressure. This observation is in 
accordance with the prevalent theory 
on the pathophysiological mechanism of 
hem orrhagic shock.
To sum m arize our resu lts : immedi­
ately a fte r the hem orrhage there is a 
sh ift of the blood flow distribution to 
the coronary and bronchial circulations, 
m ainly a t the expense of renal and skin 
circulations. Later, in anim als surviving 
the hem orrhagic shock, distribution of 
the blood flow tends to re tu rn  to nor­
mal, preserving the m oderately in­
creased coronary and liver fractions. In 
contrast, in anim als dying from  hemor­
rhagic shock the most prom inent fea­
tu re  is the sh ift of the blood flow to 
the carcass circulation, reflecting the 
term inal vasodilation. These observa­
tions are  in agreem ent w ith the curren t 
concept of pathophysiology of hem or­
rhagic shock.
Summary
Experim ental hem orrhagic shock was 
induced by rem oving 40% of the total 
blood volume in unanesthetized rats. 
D istribution of cardiac output was 
m easured by s,iRb fractionation in four 
group of ra ts :  (a) norm al animals, (b) 
immediately a fte r the blood removal, 
(c) a t the period of “stabilized” hypo­
tension, i.e. three hours a fte r  the blood
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removal and (d) in “ dying” animals in 6. 
which the blood pressure decreased to 
20 mm. Hg, irrespective of the time in­
terval. Major redistribution of the 7-
cardiac output occurred immediately
after the blood removal, the most im­
portant change being the increase in 
the coronary and bronchial fractions, 
mainly at the expense of the renal and 
skin fractions. In the animals surviving 9 
the hemorrhagic shock, distribution of 
the cardiac output tends to return to 
normal, preserving the moderately in­
creased coronary and liver fractions. 10.
Cardiac output distribution in dying
animals resembled that after the blood n . 
removal; the differences from normal 
were even more pronounced. There was 
also a significant increase in the car- 12. 
cass fraction, reflecting probably the 
terminal vasodilation in the skeletal 
muscles. 13.
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TREATMENT OF EXTENSOR TENDON INJURIES OF THE HAND*
R. M. McFARLANE, M.D., M.Sc., F.R.C.S.[Cjf and M. K. HAMPOLE, M.D., F.R.C.S.[C],f
London, Ont.
Summary: Most extensor tendon injuries of the 
fingers can be treated successfully by splinting 
alone which has the distinct advantage that 
limitation of flexion of the finger is less likely 
to ensue. Mallet-finger deformity due to an 
avulsion fracture and boutonniere deformity that 
cannot be corrected passively may require 
operation. Only on the dorsum of the hand, 
where the extensor tendons are free to retract 
when divided, is tendon suture an essential part 
of treatment.
Resume: De simples attelles suffisent pour 
traiter avec succes la majorite des lesions des 
tendons extenseurs des doigts, cette methode 
ayant en outre I'avantage que la limitation de 
la flexion du doigt risque moins de se produire. 
La difformite du doigt en marteau resultant 
d'une fracture par arrachement et cede de la 
boutonniere qu'il n'est pas possible de corriger 
passivement peuvent imposer I'intervention. Ce 
n'est que sur la face dorsale de la main, c'est-a- 
dire la ou les tendons extenseurs peuvent se 
retracter librement apres avoir ete sectionnes 
que la suture des tendons constitue I'essentiel 
du traitement.
Wh e n  seen early, an extensor tendon in­
jury of the hand responds well to treatment. 
Because of the complex anatomy of the 
extensor mechanism, it is almost impossi­
ble at the time of late reconstruction to 
restore the delicate balance of its various 
components. Therefore it is important to 
treat extensor tendon injuries early, when 
the damaged parts require only simple ap­
proximation, rather than late, when recon­
struction is likely to fall short of restoring 
normal tension within the mechanism.
When some component of the extensor 
mechanism within the digit is torn or 
divided and continuity of the tendon is 
lost, the tendon ends do not retract very 
far and even if the injury is not treated scar 
tissue will bridge the gap. If this scar tissue 
is kept to a minimum by splinting the af-
*From the Division of Plastic Surgery, The Uni­
versity of Western Ontario, 380 Queen’s Avenue, 
London, Ont.
Presented in part at the twenty-fifth annual meet­
ing of the Canadian Society of Plastic Surgeons, 
Jasper, Alta., May 5, 1971.
fClinical Professor of Surgery. 
fFormer Resident in Plastic Surgery.
fected joint in extension, normal tension can 
be restored to the various components of 
the extensor mechanism. Treatment of the 
digit in extension should not result in re­
duced flexion provided the extensor me­
chanism is not repaired with too much ten­
sion and the affected joint is not im­
mobilized too long. Limitation of flexion 
is less likely after splinting than after oper­
ative repair because the former avoids ex­
cessive tension.
During the past 10 years we have treated 
extensor tendon injuries distal to the meta­
carpophalangeal joint almost exclusively by 
splinting rather than by suture of the 
divided, or torn, tendon. To test this meth­
od of treatment, splinting was done in open 
injuries, even when the divided tendon 
ends could be seen. To evaluate this ap­
proach to the treatment of extensor tendon 
injuries, we reviewed 50 cases that were 
treated for mallet-finger deformity by splint­
ing and were examined more than one year 
later. This paper contains the results of 
this review and describes the methods we 
use to treat other types of extensor tendon 
injuries in the digit and hand.
M allet  F inger
This common flexion deformity at the dis­
tal interphalangeal joint may develop when 
the end of the finger is suddenly and force­
fully flexed. Severe injuries cause a corre­
spondingly severe degree of flexion deform­
ity and should be treated. Less severe 
injuries, by far the most common, produce 
little or no disability, so that treatment is 
of questionable value.
We have reviewed our results in 50 pa­
tients with mallet finger treated by splint­
ing; the period of follow-up was from one 
to 10 years. The series included all types 
of mallet-finger deformities, i.e. closed in­
juries, open injuries and avulsion fractures, 
whether seen at the time of injury or some 
months later. Almost 80% of these patients 
obtained an excellent or a good result from 
splinting alone (Fig. 1). On these results the 
following recommended methods of treat­
ment are based.
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NUMBER
OF
PATIENTS
Fig. 1.—The results of treatment of mallet 
finger by splinting. Excellent (E)—less than 5° 
limitation of extension, good (G)—5° to 15°, 
fair (F)—15° to 30° and poor (P)—more 
than 30° limitation.
Closed injury seen within one month of 
injury.— The distal interphalangeal joint 
is splinted in extension for six weeks. Sev­
eral types of splint are available commer­
cially or can be made and applied either 
to the volar or dorsal surface of the finger 
(Figs. 2 and 3). It is not necessary or desira­
Fig. 2a
Fig. 2b
ble to immobilize the proximal interphalan­
geal joint. Immobilization of both interpha­
langeal joints reduces hand function so 
much that the patient will probably refuse 
to tolerate the splinting for six weeks. 
There is the added risk of producing stiff­
ness at the proximal joint. With splinting 
of the distal interphalangeal joint only, the
Fig. 2c
I P K V
Fig. 2d
Fig. 2e
Fig. 2.—(a) A simple mallet finger with 60° of 
flexion. This amount of flexion is disabling and 
warrants treatment, (b) Treated by a volar metal 
splint as used by Milford.1 (c) More adhesive 
tape is added to hold the splint in place. Note 
that the finger can flex normally at the proximal 
interphalangeal joint, (d and e) Result at six 
months showing good extension and flexion.
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Fig . 3.—A type of dorsal splint made of applica­
tor sticks held together with adhesive tape. Full 
flexion at the proximal interphalangeal joint is 
possible with the splint in place.
housewife should be subject to only minor 
inconvenience, the manual labourer should 
be able to continue working and the athlete 
should suffer no restrictions. If the splint 
hampers function it can be removed during 
short periods of specific activity on the 
understanding that the duration of splinting 
must be prolonged. An intelligent patient 
can change the splint daily without allow­
ing the distal joint to flex. Usually, however, 
the patient is seen once each week when 
the splint is changed so that the skin does 
not become macerated and the position of 
extension at the distal joint is assured. After 
six weeks of continuous splinting the splint 
should be worn at night for another two 
weeks. This additional period of treatment 
may not be necessary with minor degrees of 
flexion deformity, but with a severe deform­
ity the flexion force at the distal joint will 
stretch the scar tissue even after six weeks 
of continuous splinting.
Closed injury seen more than one month 
after injury.— The distal joint is main­
tained in extension for six weeks and the 
patients wears a night splint for another 
two weeks. As shown in Fig. 4 the results 
are satisfactory even when the patient is 
seen late. Even three months after injury, 
splinting alone will probably yield a satis­
factory result. In the past 10 years no pa­
tient, regardless of how long after injury he 
was first seen, has been operated upon for 
a simple mallet-finger deformity. Most pa­
tients gained an excellent or a good result 
with splinting. The fair and poor results 
(Figs. 1 and 4) were not due to treatment 
but to poor patient co-operation or inade­
quate immobilization of the distal joint. All 
the patients treated by splinting regained 
full flexion.
Laceration of the extensor mechanism 
near the distal interphalangeal joint.— A 
laceration over the dorsum of the distal 
interphalangeal joint is likely to divide the 
extensor tendon and produce a mallet- 
finger deformity. The skin and tendon 
wounds can be closed by a figure-of-eight 
suture, which includes both layers of tissue, 
but suture of the tendon is not necessary. 
In fact, the skin need not be sutured either 
if the distal joint is immobilized in slight 
hyperextension. The type and duration of 
splinting should be the same as described 
above. The results of treatment by splint­
ing alone are the same for open and closed 
injuries (Fig. 5).
NUMBER
OF
PATIENTS
open injury
E G F P
Fig. 5.—A comparison of numbers of patients 
with closed and open mallet-finger injuries treated 
by splinting. The results are similar.
NUMBER
OF
PATIENTS
20 r up to 
one month
1 0 -
uun_
E G F P
one month to 
six months
E G
□ □
Fig. 4.— The time interval between injury and 
treatment. The results of treatment are similar in 
the group treated soon after injury and in those 
treated one to six months after injury.
Avulsion fracture of the distal phalanx. 
—This injury is not common. In most 
cases the bone fragment is very small (Fig. 
6). The injury is treated as a simple mallet 
finger by splinting for six weeks. However, 
these patients do not obtain results as good 
as those in the previous groups. Nine pa­
tients with avulsion fractures were treated 
by splinting. Three obtained an excellent 
result, three a good result and three a fair
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Fig. 6.—Avulsion of a small fragment of bone 
from the base of the distal phalanx. After this 
injury was treated by splinting for six weeks the 
patient gained full flexion and extension.
Fig. 7c
result. An unsightly mass of callus usually 
forms on the dorsum of the finger just 
proximal to the distal interphalangeal joint 
and may take one or two years to resolve. 
Also for several months patients complain 
of pain on striking the finger.
If the avulsed fragment represents more 
than one-third of the articular surface of 
the distal phalanx, operation is justified 
(Fig. 7). There is volar subluxation of the 
distal phalanx and although extension can 
be restored by conservative measures, a 
flexion deformity and disability result. 
Through a dorsal incision the avulsed frag­
ment is correctly aligned and held in place 
by a single Kirschner wire. A second 
Kirschner wire is placed across the distal
Fig. 7 c
Fig. 7.—(a) A fracture of the distal phalanx 
in which more than one-half of the articular sur­
face was avulsed. This injury should have been 
treated by open reduction and internal fixation.
(b) The finger was splinted, using a plastalume 
splint (Brown Manufacturing Ltd., Hartley, Iowa) 
on the volar surface. Splinting was continuous for 
eight weeks and at night only for four weeks.
(c) The avulsed fragment healed but note the 
volar subluxation, (d) The unsightly callus over 
the dorsum of the distal interphalangeal joint 
makes the flexion deformity more apparent, (e) 
The patient regained full flexion within one month 
of splinting.
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interphalangeal joint to hold the joint in 
extension. The wires are removed after 
three weeks but extension is maintained by 
splinting for a total of six weeks. At least 
several weeks will pass before the patient 
regains flexion and full flexion may never 
be regained.
Boutonniere  D eform ity
The injury that produces this deformity 
is not often seen early; it is most commonly 
a closed injury in which the middle slip of 
the extensor tendon is torn during dorsal 
dislocation at the proximal interphalangeal 
joint. Usually the patient or a friend can 
reduce the dislocation. The patient may or 
may not seek medical attention but, if he 
does, the radiograph proves to be negative 
and often no treatment is advised. When 
the pain and swelling subside during the 
next week or 10 days an obvious bouton­
niere deformity is evident.
The mechanism of injury is similar to 
that in mallet finger. The thrust of the 
head of the proximal phalanx tears not only 
the middle slip of the extensor tendon but 
also the fibres joining the lateral bands to 
the middle slip. If the injury is not treated 
the lateral bands slide over the side of the 
joint and become fixed in a position volar 
to the axis of joint movement. When this oc­
curs, the typical deformity appears and treat­
ment becomes more difficult. If the injury 
is treated early before the lateral bands 
become fixed in a volar position, the various 
components of the mechanism can be held 
in their normal position by splinting. Our 
treatment of the types of boutonniere de­
formity is as follows:
Deformity seen soon after injury.— The 
proximal end of the middle slip cannot re­
tract far because of its attachment to the 
lateral bands. Splinting the proximal inter­
phalangeal joint in extension reduces the 
gap in the middle slip produced by the in­
jury and prevents volar drift of the lateral 
bands although the fibres connecting the 
middle slip and lateral bands have been 
torn (Fig. 8). It is difficult to maintain the 
proximal interphalangeal joint in full exten­
sion by an external splint so the metacar­
pophalangeal joint should also be immobil­
ized in extension and the wrist held in 
dorsiflexion. A Kirschner wire inserted
Fig. 8b
Fig. 8.—(a) A mild boutonniere deformity seen 
one month after injury. The patient complained 
of pain on flexion and when the dorsum of the 
proximal interphalangeal joint was struck, (b) 
Full extension (and flexion) gained after splint­
ing the finger in extension for three weeks.
obliquely across the joint affords firm im­
mobilization; this is a more reliable way of 
holding the proximal interphalangeal joint 
in extension. A shorter splint that immobil­
izes only the metacarpophalangeal and the 
proximal interphalangeal joints can then be 
used. Splinting should continue for four 
weeks but the Kirschner wire should be 
removed at three weeks to lessen the chance 
of pin-tract infection. In older patients, the 
time of absolute immobilization should be 
reduced to two weeks and they should wear 
the splint only part of the time or at night 
for another two weeks. If the proximal in­
terphalangeal joint is held in extension too 
long in older people they may never regain 
full flexion.
Tendon laceration at the level of the 
proximal interphalanged joint.—The mid­
dle slip of the extensor tendon is vulnerable 
to a lacerating injury and occasionally the 
lateral bands are cut as well. A flexion
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Fig. 9a
Fig. 9b
Fig. 9c
deformity at the proximal interphalangeal 
joint appears immediately (Fig. 9). Whereas 
a closed tendon injury is often missed, in 
an open injury it is obvious that the tendon 
has been divided and that repair is needed. 
A Kirschner wire is placed obliquely across 
the proximal interphalangeal joint with the 
joint in extension. The various components 
of the extensor mechanism need not be iden­
tified but simply clustered together with 
figure-of-eight sutures as in repair of an 
open mallet-finger injury. The hand and 
finger are immobilized as before. The Kirsch­
ner wire is removed at three weeks and only 
the proximal interphalangeal joint immobil­
ized for another week.
Deformity seen late after injury.—This 
may be difficult to correct but in most pa­
tients splinting is all that is required. If the 
proximal interphalangeal joint can be ex­
tended passively, the lateral bands are proba­
bly not fixed volar to the axis of movement 
and splinting alone is likely to yield a good 
result. The finger should be splinted con­
tinuously for six weeks and at night for at 
least another three weeks. In this time the 
scar tissue that has established the continuity 
of the extensor mechanism shortens enough 
to correct the deformity. The patient will 
regain flexion of the digit readily.
If it is not possible passively to extend the 
proximal interphalangeal joint a period of 
spring splinting is indicated (Fig. 10). It 
may take three or four weeks to gain full 
extension. Once this has been reached the 
finger should be immobilized in extension at 
the proximal interphalangeal joint for six 
weeks. Usually operation is not required, 
but if it is, the various tendons and liga­
ments about the proximal interphalangeal 
joint are in an ideal position for recon­
struction.
Fig. 9.—(a) A laceration of the index finger 
at the insertion of the middle slip of the extensor 
tendon. The finger im mediately assumed the 
boutonniere deformity, (b) W ith a Kirschner w ire 
placed across the proximal interphalangeal joint 
in full extension, the deform ity is corrected, (c) 
The skin and tendon ends are held by figure-of- 
eight sutures, (d) All joints of the finger are 
held in extension. The patient would have been 
more com fortable in a longer splint that would 
immobilize the wrist, but a shorter splint can be 
used for convenience as in this patient— a 
physician. After two weeks active movement at 
T*g- the distal interphalangeal joint is encouraged.
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Fig. 10b
Fig. 10.—(a) An untreated boutonniere de­formity first seen three months after injury. It was not possible passively to correct the de­formity. (b) A spring splint was worn continu­ously for five weeks and full passive correction was obtained. A simple extension splint was worn for another six weeks and full extension (and flexion) resulted.
There remains a small group of patients 
in whom splinting is unsuccessful or fails 
to effect full extension at the proximal inter- 
phalangeal joint. A number of operations 
have been described, all of which are suc­
cessful in gaining extension. The common 
disadvantage of these operations is that they 
do not ensure full flexion of the digit. For 
this reason alone one should be cautious in 
advising operation for boutonniere deform­
ity.
We use two different procedures for the 
surgical repair of boutonniere deformity: 
(1) If the proximal interphalangeal joint can 
be fully extended by splinting and yet the the 
deformity recurs when splinting is discontin­
ued, we do a simple Y to V shortening of the 
scar tissue near the insertion of the middle 
slip (Fig. 11). In these circumstances the 
lateral bands need not be disturbed. The
proximal interphalangeal joint is immobilized 
in extension by an oblique Kirschner wire 
and the middle slip, with its attached scar, is 
advanced distally just enough to take up the 
slack in the scar tissue. As before, the finger, 
hand and wrist are splinted in extension for 
three weeks, the Kirschner wire is removed 
and the proximal interphalangeal joint only 
splinted for another week or two depending 
on the patient’s age. (2) If the boutonniere 
deformity cannot be corrected by splinting, 
we do a more extensive operation. The 
proximal interphalangeal joint must first be 
extended, and to do this one of several struc­
tures must be divided. As Curtis2 described, 
Landsmere’s ligaments are divided bilater­
ally. If this does not permit extension, 
portions of the vertical component of the 
collateral ligaments are excised. Usually the 
joint can be extended after one or both of 
these procedures. If extension is still not 
gained, the volar plate of the proximal in­
terphalangeal joint is exposed and divided 
proximally. This is a last resort because the 
patient will probably not regain good move­
ment at the joint if division of the volar 
plate and a reconstructive procedure on 
the dorsum of the same finger are required. 
Once the proximal interphalangeal joint is 
fully extended the finger is held in this 
position by an oblique Kirschner wire. 
Under these circumstances the extensor 
mechanism is best reconstructed after the 
method of Littler and Eaton.2' No attempt 
is made to repair the damaged extensor 
mechanism but a new extensor system is 
created by placing the lateral bands over 
the dorsum of the interphalangeal joint. 
This operation has the distinct advantage of 
not interfering with tensions about the joint. 
The lateral bands are folded upon them­
selves so that they pull over the dorsum of 
the joint rather than more laterally. This 
operation achieves extension but does not 
compromise flexion. Postoperatively the 
hand is immobilized for five weeks as 
before.
T endon Division at the L evel of the
Metacarpophalangeal Joint
A laceration at this level divides the cen­
tral tendon and a varying amount of the 
extensor hood on either side. Often the 
limitation of extension at the metacarpo-
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Fig. l i e
Fig. 11.—(a) A severe boutonniere deformity 
of six months’ duration, (b) The deformity was 
correctable passively, (c) At operation the middle 
slip with its attached scar tissue was mobilized 
and advanced in a Y-V fashion, (d and e) One 
year after operation extension was maintained but 
flexion was restricted at the distal interphalangeal 
joint.
phalangeal joint is slight at the time of in­
jury and may be missed. If not treated the 
deformity becomes progressively more 
severe. When the extensor tendon is 
divided it does not retract far from 
its distal end, hence the metacarpo­
phalangeal joint can be splinted in ex­
tension as in the case of a fresh injury at 
the distal or proximal interphalangeal joint 
(Fig. 12). In our experience this method of 
treatment is successful. However, because 
there is a laceration it seems reasonable 
to place figure-of-eight sutures through the 
skin and tendon at the time of skin closure. 
The joint should be held in extension for 
three weeks. Kirschner wire fixation is not 
necessary because it is easy to hold the joint 
in extension with an external splint. A 
smaller splint can be applied for another 
week if this is thought necessary.
If this injury is missed and is seen late, 
the scar tissue between the tendon ends 
should be resected and the tendon sutured.
T endo n  D ivision  O ver  the  D o r s u m
of the  H and
Extensor tendon injuries at this level in­
variably are due to laceration. The extensor 
tendons are free to retract a considerable 
distance when they are divided. Therefore 
suture of the tendons is as important as 
immobilization. A simple mattress or fig­
ure-of-eight suture is sufficient to approxi­
mate the tendon ends. The hand is then 
immobilized with the wrist in extension,
Fig. 11a
Fig. l ib
Fig. 11c
Fig. l id
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Fig. 12b
Fig. 12d
the metacarpophalangeal joints in extension 
and the proximal interphalangeal joints in 
slight flexion. For single tendon injuries the 
middle finger should be immobilized with 
the index, the ring with the middle, and 
the little with the ring finger. When more 
than one tendon has been divided all fingers 
are immobilized. This position should be 
maintained for three or four weeks, depend­
ing on the age of the patient. If the period 
of immobilization is longer, the patient will 
not gain flexion of the fingers for several 
months, or may even lose it permanently 
(Fig. 13).
E x t e n s o r  T e n d o n  In j u r ie s
o f  th e  T h u m b
Extensor tendon injuries of the thumb 
are treated in the same way as those of 
the fingers and hand. Mallet “thumb” can 
be the result of either a closed or open in­
jury and should be treated in the same way. 
Lacerations at the level of the metacarpo­
phalangeal joint are common and extensor 
tendon repair at this level is frequently 
unsuccessful. The extensor pollicis longus 
and brevis tendons should be sutured sepa­
rately. A Kirschner wire is inserted oblique­
ly across the joint to maintain extension 
because it is difficult to hold this metacar­
pophalangeal joint in extension by external 
splinting. The hand should be supported 
with the wrist and thumb in extension for 
three weeks in a plaster cast.
When the long or short extensor tendons 
are divided at a more proximal level they 
should be repaired in the same way as an 
extensor tendon injury on the dorsum of 
the hand. If delayed until later, such re­
pairs usually require excision of the scar 
tissue between the severed ends, and tendon
Fig. 12.—(a) A laceration over the dorsum of the metacarpophalangeal joint of the long finger which divided the extensor tendon. The lack of full extension could easily be missed, (b) By ex­tending the finger the tendon ends were approxi­mated. Only the skin was sutured, (c) The hand and wrist were immobilized in a volar splint for three weeks. This type of splint is used for all extensor tendon injuries from the level of the proximal interphalangeal joint to the wrist, (d) A plastalume splint immobilized only the metacar­pophalangeal joint for another week. The patient regained full extension and flexion within six weeks of discontinuing splinting.
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Fig. 13a
Fig. 13b
Fig. 13c
Fig. 13d
Fig. 13e
Fig. 13.—(a) A severe laceration of the dorsum 
of the hand that divided all of the extensor 
tendons to the fingers. All tendons were repaired 
primarily and the hand and wrist immobilized in 
extension for five weeks, (b and c) Appearance 
of the hand one month after discontinuing splint­
ing. The wounds have healed well but the hand is 
still swollen and there is marked limitation of 
flexion of the fingers, (d and e) Six years later 
the patient has full extension of all fingers but is 
still unable to make a tight fist. The period of 
immobilization following tendon repair was too 
long.
suture. If the ends of the extensor pollicis 
longus tendon cannot be approximated a 
transfer of the extensor indicis proprius to 
the distal tendon end is preferable to suture 
under tension or a free tendon graft.
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FIBROMA OF PLEURA: A CASE REPORT*
M. ALI MADANI, M.D.. HERBERT F. SCHWARTZ, M.D, and N. RICHARD GERSHON, M.D.,Kingston, N.Y., V.S.A.
Summary: A 46-year-old woman had a pedun­
culated fibroma of the visceral pleura attached 
to the right middle lobe. It was resected at 
operation. Benign tumours of the pleura are 
relatively rare. The site of origin is usually the 
visceral pleura and in about one-half of the 
cases the tumour is attached by a narrow pe­
dicle which leaves it free to move about in the 
pleural cavity. In the past, some of the very 
highly cellular fibromatous tumours of pleura 
were misdiagnosed as fibrosarcoma. Excision is 
the cure and recurrence is rare. Should this 
happen, the malignant potentiality of the original 
tumour must be suspected.
Resume: Une femme de 46 ans presentait un 
fibrome pedoncule de la plevre viscerale. Reuni 
au lobe moyen droit, il fut enleve par resection. 
Les tumeurs benignes de la plevre sont relative- 
ment rares. Ms ont generalement leur origine 
dans la plevre viscerale et, dans pres de la 
moitie des cas, la tumeur y est fixee par un 
etroit pedicule qui la laisse libre de se mouvoir 
dans la cavite pleurale. Autrefois, on portait le 
diagnostic errone de fibrosarcome dans certains 
cas de tumeurs cellulaires de la plevre fortement 
fibromateuses. L'excision est le seul traitement 
et la recidive est rare. Si elle devait survenir, on 
devrait envisager la possibility d'une evolution 
maligne de la tumeur originelle.
P r im a r y  tumours of the pleura are in­frequent and the surgeon rarely makes a correct preoperative diagnosis. Pa­tients with this condition usually have no symptoms and their chest lesions are discovered coincident with some other procedure or examination. The lesion arises from either visceral or parietal pleura and in about one-half of patients it is pedunculated. Surgical excision is the treatment of choice. Recurrence is extremely rare. The patient whose case is reported below was asymptomatic and the lesion was discovered during a routine roentgenogram of the chest. At operation we removed a pedunculated lesion attached to the right middle lobe. The pathological findings were consist­ent with fibroma of the pleura.
*From the Kingston Hospital, Kingston, N.Y., V.S.A.
Case  R eport
The patient, a 46-year-old woman, was ad­
mitted to the Kingston Hospital, Kingston, 
New York on September 10, 1968 for inves­
tigation of a radiodensity of the right lung 
field. The lesion had been discovered on a 
routine pre-employment radiograph of the 
chest five weeks previously. Initially she had 
no symptoms but did complain of some dry 
cough after being told about her chest lesion. 
Her past history was not contributory. No pul­
monary disease or trauma to the chest was 
known and she had not had any contact with 
asbestos dust. She had smoked cigarettes mod­
erately for 20 years. Her last chest film taken 
three years before was negative. The physical 
findings were unremarkable. There was no 
clubbing of the fingers and no joint manifes­
tations.
Admission roentgenograms of the chest re­
vealed a sharply defined ovoid mass in the 
right costophrenic sinus (Fig. 1). The lesion 
had not changed in the five-week interval. Ad­
mission hemoglobin was 13.7 g./lOO ml.; leu­
kocyte count was 5,000/c.mm. with 45% neu­
trophils, 40% lymphocytes, 10% monocytes 
and 4% eosinophils. Skin tests for tuberculosis 
and fungus infections were negative. Cytolog­
ic studies of the sputum were not diagnostic. 
The investigations of the gastrointestinal and 
genitourinary tracts showed no remarkable 
findings.
On September 12, 1968, at right thoracot­
omy, the tumour, which was attached by a 
pedicle to the inferior anterior aspect of the 
right middle lobe, was removed together with 
a portion of the adjacent normal lung. The 
tumour was well encapsulated, quite firm in 
consistence, and roughly ovoid, measuring 7 
cm. in its greatest dimension. On cross-section 
il was greyish-white to pink and a fibrous 
whorl pattern was visible. Microscopically the 
tumour was composed almost entirely of fi­
brous tissue with a variable degree of cellular- 
ity (Fig. 2). The findings were consistent with 
fibroma of the pleura.
Three years after operation the patient is 
free of symptoms, with no evidence of recur­
rence.
D isc u ssio n
Primary tumours of the pleura, which are relatively rare, are divided into two
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Fig. la Fig. lb
Fig. 1.—(a) Posteroanterior and (b) right lateral projections showing a 7-cm. soft tissue 
mass in the right anterior costophrenic sinus.
main clinical groups: localized and dif­
fuse. Localized tumours are usually be­
nign, discrete and more often attached 
to the visceral than to the parietal 
pleura. The diffuse primary pleural neo-
Fig. 2.—Microscopic appearance of the benign 
fibroma of the pleura showing interweaving 
bundles of fibroblasts lying in a matrix of col­
lagen fibres (H & E x 200).
plasm, by contrast, is almost always 
malignant, usually arises from the pa­
rietal pleura, and involves a large por­
tion of the pleural surface.
Most patients with benign primary 
tumours of the pleura have been asymp­
tomatic. Symptoms, if present, vary 
from mild cough, feeling of vague dis­
comfort and heaviness in the chest, to 
dyspnea, chest pain, and chills and 
fever. Joint manifestations and club­
bing of the fingers have also been re­
ported.1’ 2 Occasionally pleural effusion 
has been associated with benign pleural 
tumours, but cytologic studies of this 
fluid have not been diagnostic.3 
The symptoms generally disappear 
after surgical removal. Recurrence is 
rare and if a tumour does recur after 
resection it is probably malignant.
Primary pleural fibroma was first es­
tablished as an entity by Stout and Mur­
ray in 1942.4 Depending upon the most 
prominent constituent cell, these lesions 
appear in the literature under different 
terms, viz. fibroma, fibrous mesotheli­
oma, epithelial mesothelioma, and local­
ized or benign mesothelioma.3’ 6 These 
tumours may originate from the sub- 
pleural connective tissue, from the con­
nective-tissue layers of the pleura itself,
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or from the mesothelial cells of the pleura. They are ovoid or lenticular, firm and well encapsulated. As a rule, they are vascular with dilated veins often visible on their surfaces. Most are attached by a relatively narrow vascu­lar pedicle to visceral or parietal pleura and move freely in the pleural cavity. These lesions grow relatively slowly, but they may reach a considerable size. A fibroma of the pleura reported by Cla- gett and Hausmann7 weighed about 5 kg. The incidence is greater after the age of 40 and there is no sex predilec­tion.3
Microscopically these fibromas are composed of interweaving bundles of fibroblasts lying in a collagenous tissue. In the past some of the more highly cellular tumours were misdiagnosed as fibrosarcoma or neurofibrosarcoma.Localized benign tumours of the pleura generally present as a discrete radiodensity, ovoid or roughly lenticu­lar. They are attached to the visceral pleura covering the lung surface and the interlobar fissures, or to the surface of parietal pleura over the chest wall, mediastinum and diaphragm. About 40 % to 50% of the attachment is by narrow pedicle, which leaves the lesion free to move about in the pleural space.8’ 9 This movement can be seen during radiography when the patient changes position or with respiratory movement. Roentgenographic studies using diagnostic pneumothorax can help to determine whether the mass is at­tached to the lung, the chest wall, the mediastinum or the diaphragm.3 A pleural fibrin ball, which may develop
after long-standing pneumothorax, can mimic localized pleural tumour.The tumour should be removed along with a rim of adjacent normal tissue. After its excision any associated symp­toms usually disappear. If the tumour recurs, the surgeon should suspect ma­lignancy and have the original speci­men reviewed with this in mind.
The authors wish to thank Mrs. Dorothy Doice, medical librarian of the Kingston Hos­pital Library, Kingston, New York, for her assistance in preparing this manuscript.
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ENZYME HYDROLYSIS IN THE BLADDER: ITS POSSIBLE 
APPLICATIONS IN THE CHEMOTHERAPY OF BLADDER CANCER*
J. G. CONNOLLY, M.D., C. PROMISLOW, M.Sc., B. G. MOBBS, Ph.D.,
S. WOWCHUK, B.Sc. and G. M. HALSALL, B.Sc., Toronto, Ont.
Summary: Normal rat and human bladder
mucosa was found to contain significant 
amounts of beta-glucuronidase. Stilbestrol glu- 
curonide was instilled into isolated intact rat 
bladders at pH 5.0 and at the more physiologic 
pH of 6.5. After two hours at pH 5.0 the blad­
der mucosa still retained a significant amount 
of stilbestrol, the product of beta-glucuronidase 
hydrolysis of stilbestrol glucuronide. The en­
zyme pathway involved influences the degree 
of retention within the bladder wall. The dura­
tion of retention and the amount of active 
compound found may be of clinical significance. 
Thus, by selection of appropriate compounds 
and by manipulating the physical conditions of 
instillation it is possible that results better than 
those previously obtained could be achieved 
with topical chemotherapy in the treatment of 
superficial bladder tumours.
Resume: On a demontre que la muqueuse ve­
sicate du rat normal et de I'homme contient 
des quantites appreciates de beta-glucuroni­
dase. Nous avons instille dans des vessies 
isolees intactes de rat du glucuronide de 
stilbestrol au pH 5.0 et au pH plus physiologique 
de 6.5. Apres deux heures de contact avec la 
solution au pH 5.0, la muqueuse vesicale con- 
tinuait de retenir une quantite notable de stil­
bestrol, produit de I'hydrolyse par le beta- 
glucuronidase du glucuronide de stilbestrol. La 
voie enzymatique influen?ait le degre de reten­
tion dans la paroi vesicale. Or, la duree de cette 
retention et la quantite de compose actif res- 
tante peuvent avoir une nette signification 
Clinique. De sorte que, en choisissant les com- 
posants appropries et en manipulant judicieu- 
sement les conditions physiques de I'instilla- 
tion, on peut obtenir des resultats meilleurs 
que ceux qu'on obtenait anterieurement par uti- 
lisant la chimiotherapie topique dans les tu- 
meurs vesicales superficielles.
Carcinoma of the urinary bladder is a 
disease that involves the entire urinary tract 
epithelium. Carcinogens are probably ex­
creted in the urine and because the bladder 
is a reservoir urothelial tumours most 
frequently develop in this organ. (It is of
‘From the Division of Urology, Department of 
Surgery, Women’s College Hospital, and the Uni­
versity of Toronto, Toronto, Ont.
interest that 60% of patients with super­
ficial carcinoma of the bladder will have 
tumour recurrences within three years.) 
Because tumoricidal agents can easily be 
instilled into the bladder, topical chemo­
therapy is an attractive method for treat­
ment of superficial bladder tumours. While 
encouraging results have been obtained in 
some instances,1, 2 this approach has not 
been entirely successful. This may be owing 
to the rapid absorption of some of the com­
monly used drugs; for example, thio-tepa 
may be completely absorbed in one hour.3 
Ideally a chemotherapeutic compound should 
remain in the bladder cavity and bladder 
wall for significant periods of time in order 
that the drug may exert its effect. Because 
bladder tumours in man contain large 
quantities of beta-glucuronidase we elected 
to study the in vivo functions of this en­
zyme; we wished to determine if this in­
formation could assist us in controlling the 
absorption rate of drugs from the bladder 
and thus aid in the design of a topical 
chemotherapeutic compound.
Materials and M ethods
We first determined the amount of beta- 
glucuronidase activity in normal rat and 
human bladder mucosa and in human blad­
der tumours using the method of Talalay, 
Fishman and Huggins.4 The physical con­
ditions necessary for hydrolysis of stilbestrol 
glucuronide were also determined using 
normal rat bladder homogenates (2% w/v) 
at pH 5.0 (acetate buffer) in the presence 
and absence of a beta-glucuronidase inhibi­
tor (saccharo 1:4 lactone, 1 x 10’4M, Sigma 
Chemical Company, St. Louis),5 and at pH 
6:5 (phosphate buffer).
Using Wistar male rats, an isolated blad­
der preparation was made by exposing the 
bladder and ureters through a lower midline 
abdominal incision (Fig. 1). The ureters 
were ligated in continuity at the uretero­
vesical junction. A no. 26 needle was passed 
along the urethra and the bladder was
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Fig. I.—Isolated rat bladder preparation.
washed several times with appropriate buf­
fers. The test solution containing stilbestrol 
glucuronide was then instilled into the 
bladder and the needle was withdrawn as 
the urethra was ligated with silk. Tritiated 
stilbestrol monoglucuronide (specific activ­
ity of 4.24 /uCi/mg.) was prepared using 
accepted techniques.6 It was instilled into 
the isolated bladder for periods of one-half, 
one, two, three and four hours in 0.6 ml. 
of vehicle (acetate or phosphate buffer). 
Three animals were killed at each time 
period.
A sample of blood was removed from 
the aorta just before the animals were 
killed by air embolism. The bladder was 
removed and ±0.05 ml. of the instilled 
solution was aspirated. The bladder was 
then washed twice with the vehicle. The 
instilled solution plus the washings, the 
bladder and the serum were prepared for 
liquid scintillation counting using established 
techniques.7
R esults
The beta-glucuronidase content of rat 
bladder mucosa is 2,413 Fishman units, 
of human bladder mucosa 342 Fishman 
units (average of 19 determinations; range 
58 to 796) and of human bladder tumours 
2,479 Fishman units (average of 11 de­
terminations; range 1,456 to 4,000). The 
enzyme activity of human bladder tumours 
is seven times, and according to Boyland’s 
data8 four to 10 times, that of normal 
bladder mucosa. We found that 97% of 
the beta-glucuronidase activity of rat blad­
der was located in the mucosa, even though
the latter accounts for only 15% of the 
bladder weight.
In vitro, at pH 5.0 a rat bladder homo­
genate will hydrolyze 90% of the stilbestrol 
glucuronide in three hours. However, at the 
more physiologic pH 6.5 only 34% hydro­
lysis occurred after three hours. The beta- 
glucuronidase inhibitor, saccharo 1:4 lac­
tone, almost completely inhibited hydrolysis 
at pH 5.0 and thus confirms the identity of 
the hydrolyzing enzyme (Fig. 2).
T IM E  (HRS.)
Fig. 2.—Hydrolysis of stilbestrol glucuronide by 
2% bladder homogenates.
When tritiated stilbestrol glucuronide is 
instilled into the intact rat bladder at pH 
5.0 rapid hydrolysis occurs (Fig. 3). At one 
hour 46% of the instilled radioactivity was 
in the hydrolyzed, lipid-soluble form (free 
stilbestrol) and 30% was in the conjugated, 
water-soluble form (glucuronide). The stil­
bestrol, both free and conjugated, was trans­
ferred across the bladder wall by simple 
diffusion as there was no loss of instilled 
volume but there was loss of radioactivity, 
which occurred at a steady rate of 21% of 
the initial dose per hour. Because blood 
samples could not be obtained from the
Fig. 3.—Recovery of radioactivity from the blad­
der solution after instillation of tritiated stilbestrol 
glucuronide (pH 5.0).
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small rat vesical veins the ratio of stil- 
bestrol g!ucuronide:stilbestrol leaving the 
bladder via the blood stream was not meas­
ured. However, we do know that stilbestrol 
is preferentially absorbed by the bladder 
mucosa.9 The blood from the aorta con­
tained approximately 1.5% of the instilled 
radioactivity per millilitre of serum.
When stilbestrol glucuronide was instilled 
at pH 6.5 there was little absorption 
(4% of the dose per hour) and little hydro­
lysis (14% at four hours). This accumula­
tion of product probably reflects the poor 
absorption of conjugated and free stilbestrol 
at this pH. Lack of hydrolysis is explained 
by the fact that pH 6.5 is outside the optimal 
range (pH 4.5 to 5.4) for beta-glucuronidase 
activity. This is in contrast with the in vitro 
results where 34% was hydrolyzed in three 
hours at this pH. The reason for this ob­
servation may be that the enzyme is made 
more available when tissue homogenate is 
used.
TIM E (HRS.)
Fig. 4.—Recovery of radioactivity from the 
bladder wall after instillation of tritiated stil­
bestrol glucuronide (pH 5.0).
Fig. 4 shows the percentage of radio­
activity recovered from the bladder wall 
when the glucuronide was instilled at pH 
5.0. The bladder wall retained a significant 
amount of liberated stilbestrol (16% and 
14% of the initial dose at one and two 
hours respectively).
Probably much of the hydrolysis occurs 
within the bladder, but undoubtedly some 
occurs within the bladder mucosa as well. 
This retention of the hydrolyzed product 
within the bladder wall is of interest and 
could be significant. When stilbestrol di­
phosphate is instilled into the isolated rabbit 
bladder, at no time in the experiment does 
the bladder wall retain more than 6% of 
the instilled dose, even though hydrolysis
occurs at a much faster rate (47% of the 
dose per hour).9 It is thus possible that 
conditions which favour rapid absorption 
may inhibit intracellular retention.
D isc u ssio n
The in vivo experiments indicate that 
the beta-glucuronidase in the isolated rat 
bladder can hydrolyze various compounds 
which are in the inactive glucuronide form. 
The degree of hydrolysis of stilbestrol glu­
curonide instilled into the rat bladder at 
pH 5.0 was directly related to the enzyme 
activity during the first two hours. Both the 
instilled solution (Fig. 3) and the bladder 
wall (Fig. 4) contained significant quantities 
of the liberated stilbestrol. Under more phy­
siologic conditions (pH 6.5) there was only 
slight enzyme hydrolysis because this pH 
is outside the optimal range for beta-glu­
curonidase activity.
It is generally accepted that the osmolality 
of a solution affects absorption across a biol­
ogical membrane. However, pH also in­
fluences absorption by affecting the lipid 
solubility of a drug and by controlling the 
rate of enzyme hydrolysis of a conjugated 
drug. Numerous investigators10- 11 have 
stated that damaged mucosa absorbs drugs 
more readily than does normal tissue. 
Hicks12 reported that proteolytic agents, 
lipid solvents and 0.01N NaOH damaged 
bladder mucosa, whereas 0.0IN HC1 did 
not, and so the absorption we observed at 
low pH was not due to mucosal damage.
Although many absorption studies have 
been performed, little is known concern­
ing the factors that influence intracellular 
retention of drugs. Once a drug has pene­
trated the cell membrane it is chiefly its 
degree of binding which determines its re­
tention. The therapeutic adequacy of a drug 
depends upon the length of time it is re­
tained. Despite its great importance, inter­
cellular binding has generally been neglected.
Because human bladder tumours contain 
large quantities of beta-glucuronidase it may 
be possible to design a suitable topical 
chemotherapeutic agent in the glucuronide 
form to treat superficial bladder tumours. 
We have shown in our in vitro studies that 
human bladder tumour homogenates can 
hydrolyze substrates of phenolphthalein
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glucuronide. Therefore the possibility exists 
that a similar system may operate in vivo. 
Connors and Whisson13 showed that in 
mice tumours containing high beta-glucu­
ronidase levels, 100% tumour regressions 
occurred when aniline mustard was given 
to the animals. The hypothesis advanced 
by these workers was that the mustard was 
converted to the glucuronide form in the 
liver and subsequently hydrolyzed by the 
beta-glucuronidase within the tumour. We 
have recently obtained a supply of aniline 
mustard glucuronide and are planning to 
study its effects on experimental bladder 
cancer.
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LA MYELOGRAPHIE GAZEUSE DANS L’ETUDE DE LA 
DIASTEMATOMYELIE
D. DILENGE, M.D.* et M. HEON, M.D., F.R.C.S.[C],t Sherbrooke, Que.
Resume: La myelographie gazeuse n'a ete que 
tres peu employee jusqu'a present dans les 
cas de diastematomyelie. Cette methode radio- 
graphique, d'apres notre experience, permet 
pourtant d'apporter dans ces cas des donnees 
semiologiques fort utiles a I'etude de la moelle 
et eventuellement de la diplomyelie, ainsi que 
de leurs rapports avec le rachis malforme. Deux 
observations sont rapportees pour souligner 
I'interet d'une telle methode pour la mise en 
evidence et I'examen de deux diplomyelies en 
rapport avec la presence d'eperons osseux et 
osteo-fibreux dans le canal rachidien lombaire.
Summary: Air myelography has hitherto been 
used only infrequently in cases of diastemato- 
myelia. This radiographic technique, in our ex­
perience, contributes useful information to the 
examination of the spinal cord and therefore 
of diplomyelia, including the relationships with 
the spinal malformation. The value of the 
method is demonstrated in two cases of 
diplomyelia associated with the presence of 
bony and fibro-osteal spurs in the lumbar spinal 
canal.
L’etude radiologique de la diastematomyelie 
peut devenir assez complexe dans de nom- 
breux cas et ceci, malgre l’emploi de la 
tomographie; les deformations vertebrales 
peuvent etre, en effet, mal definissables, 
surtout chez les enfants ages de moins d’un 
an et l’eperon caracteristique de cette mal­
formation, notamment lorsqu’il est peu cal- 
cifie, peut n’etre pas evident sur les radio- 
graphies. L’emploi de la myelographie, 
d’apres les travaux publies jusqu’a date, 
semble etre necessaire dans tous les cas ou 
ce type de malformation est suspecte. La 
myelographie opaque, faisant recours aux 
huiles iodees, a permis de prouver, dans 
la plupart des cas, la separation de la cavite 
rachidienne au niveau de l’eperon1- 2 et 
meme lorsque celui-ci est de consistance 
fibro-cartilagineuse: dans quelques cas3 elle 
a permis de decouvrir, en outre, des adhe-
♦Departement de Radiologie, Centre Hospitalier 
Universitaire, Universite de Sherbrooke, Sher­
brooke, Que.
fDepartement de Neuro-chirurgie, Centre Hos­
pitalier Universitaire, Universite de Sherbrooke.
rences arachnoidiennes perimedullaires au 
niveau de la malformation. La myelogra­
phie gazeuse n’a ete que tres peu employee 
jusqu’a present.4 Cette technique, d’apres 
notre experience, permet pourtant d’appor- 
ter des donnees precieuses a I’etude de la 
moelle soit en rapport avec les deformations 
qui la caracterisent, soit en rapport avec 
la malformation osseuse. Nous avons ainsi 
selectionne deux cas bien typiques ou une 
telle technique s’est averee particulierement 
interessante.
H istoire de Cas
Cas 1.-.—A.P. II s’agit d’une petite fille de 
3 ans traitee a l’age d’un mois pour myelo­
meningocele et trois mois plus tard par valve 
de Holter pour hydrocephalie. II persiste de- 
puis la naissance une paraparesie affectant 
plus particulierement le membre inferieur gau­
che, qui n’a pratiquement aucun mouvement. 
L’enfant a pu s’asseoir a l’age d’un an, mais 
ne peut se tenir debout. II persiste egalement 
une incontinence urinaire qui, par periodes, 
est plus ou moins importante.
Au moment de son hospitalisation, le fonc- 
tionnement de la valve de Holter parait etre 
suffisant, mais la circonference de la tete est 
un peu plus importante qu’elle devrait 1’etre. II 
n’y a aucun signe d’infection. On note a la 
region lombo-sacree une cicatrice bien guerie 
de myelo-meningocele, avec formation de 
bourrelets a l’endroit du tissu epithelial, anor- 
mal, caracteristique de la meningocele. II y 
a paraparesie aux membres inferieurs; le 
membre inferieur gauche n’est pratiquement 
pas fonctionnel, mais il y a des mouvements 
dans tous les secteurs du membre inferieur 
droit. On constate une analgesie du membre 
inferieur gauche remontant jusqu’a L I. II y 
a hypoalgesie a L3, du cote droit. Les reflexes 
osteo-tendineux ne sont pas mis en evidence 
au niveau des membres inferieurs. L’examen 
radiologique du crane montre une augmenta­
tion du diametre sagittal et lateral ainsi qu’une 
reduction de Fepaisseur des os de la voute; il 
permet de reconnaitre, egalement, la presence 
d’une valve de Holter. Une cystographie fait 
connaitre une mega-vessie et un reflux vesico­
ureteral du cote gauche. A l’examen du bassin, 
il y a les signes d’une subluxation de la hanche
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Fig. 1.—Cas 1. L’eperon osteo-fibreux (fleches) 
est mis en evidence dans son aspect le plus carac- 
teristique par une coupe tomographique en pro­
jection sagittale. II presente une base large d’as- 
pect fibreux, paraissant en rapport avec les corps 
vertebraux de L2-L3-L4. Le corps vertebral de 
L3 est nettement hypoplasique.
Fig. 2a
Fig. 2c
Fig. 2.—Cas 1. (a) Les fleches indiquent les 
cordons medullaires deja nettement separes au 
niveau de D ll. (b) Le cordon medullaire droit 
est bien visualise au niveau de l’eperon et il 
semble contenu dans une cavite separee jusqu’a 
son segment terminal, (c) Le cordon medullaire 
gauche est mal definissable (fleches) et on l’aper- 
coit a peine, seulement au-dessus de l’eperon; 
plus distalement l’espace sous-arachnoi'dien n’est 
plus injecte autour de ce cordon, en raison de 
l’existence de brides arachnoidiennes et d’adhe- 
rences meningees.
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droite et d’une luxation de la hanche du cote 
oppose. L’examen radiologique de la colonne 
vertebrale decouvre un somatoschisis de DIO 
et une augmentation de la distance inter- 
pedonculaire qui progresse caudalement a 
partir de D7. La colonne lombaire apparait 
nettement deformee et elle presente un elar- 
gissement tres important du canal rachidien, 
avec amincissement des pedicules et deforma­
tion des corps vertebraux. Le corps vertebral 
de L3 est tout particulierement hypoplasique. 
En regard de ce corps vertebral, il y a un 
septum osteo-fibreux dont la base d’implan- 
tation semble atteindre, egalement, la surface 
posterieure du corps de L2 et du corps de L4 
(Fig. 1). Ce septum divise le canal en deux 
cavites.
La myelographie gazeuse (Figs. 2 et 3) per­
mit d’objectiver une division de la moelle des 
les derniers segments dorsaux (Fig. 2a). Le 
cordon lateral droit a ete mis en evidence dans 
tout son ensemble (Fig. 2b) et meme en pro­
jection laterale (Fig. 4). Le cordon gauche
1 2
I
3
Fig. 3.—Schema de la fig. 2. 1 =  cordon me- 
dullaire droit; 2 =  cordon medullaire gauche; 
3 =  l’eperon qui separe la cavite rachidienne 
lombo-sacree.
Fig. 4.—Cas 1. Par cette coupe tomographique 
il a ete possible d’objectiver le cordon lateral 
droit en projection sagittate. Noter la bonne de­
finition des contours medullaires ainsi que des 
racines.
n’est pas partiellement visible (Fig. 2c) et tres 
peu de contraste gazeux semble se trouver 
dans la moitie gauche du canal lombo-sacre. 
Cet aspect myelographique paraissait evoquer 
la presence d’adherences ou de compressions 
au niveau du cordon medullaire gauche.
Cas 2.—J.O. 11 s’agit d’une autre petite fille 
de 8 mois, nee a terme (forceps), qui a ete 
suivie depuis la naissance pour une malfor­
mation du tronc et de la region lombaire. Des 
sa naissance, elle presentait, en effet, un 
cephalo-hematome bilateral, un tout petit tronc 
et une attitude cyphotique de la colonne lom­
baire. A l’age de 2Vi mois, sa deformation 
cyphotique de la colonne lombaire est nette­
ment evidente et elle s’accompagne d’une 
tumefaction lombaire gauche. Cette tumefac­
tion est devenue nettement evidente un mois 
plus tard; elle mesure alors 4 cm de diametre 
et elle est de consistance molle, fluctuante. Il 
y a une hypertrichose cutanee a 1’endroit de 
cette masse. On constate egalement un pied 
plat bilateral et une anomalie du cinquieme 
orteil. Par ailleurs, il semble exister une diffe­
rence importante de la longueur des deux 
membres inferieurs; cote droit 26 cm, cote 
gauche 23 cm.
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Fig. 5b
Fig. 5.—Cas 2 (a et b). En projection antero- 
posterieure, les coupes tomographiques permettent 
de situer l’endroit precis de !a bifurcation medul­
la ire, tout pres de DIO, nettement au-dessus de 
l’eperon osseux (fleches) qui semble situe au ni­
veau de L1-L2-L3. II semble s’agir, cependant, 
d’une separation partielle a ce niveau puisque sur 
(b) on peut noter une jonction medullaire assez 
marquee entre les deux cordons; ensuite ces deux 
cordons s’ecartent definitivement pour passer au- 
tour de l’eperon et se diriger vers la gauche. Le 
cordon medullaire droit est plus nettement en con­
tact avec l’eperon et il semble presenter un calibre 
manifestement reduit pres de celui-ci.
L’examen radiologique du poumon et du 
systeme urinaire ne montre pas de modifica­
tion pathologique evidente. La colonne verte- 
brale, par contre, presente une deformation 
cypho-scoliotique de la region dorso-lombaire. 
II y a une dilatation de la cavite rachidienne 
a partir des premieres vertebres dorsales, qui 
progresse caudalement jusqu’a devenir tres
Fig. 6.—Schema de la Fig. 5. 1 =  moelle epiniere 
au-dessus de la division; 2 =  pont medullaire 
entre !es deux cordons medullaires qui apparais- 
sent deja separes au-dessus de ce niveau; 3 =  cor­
don medullaire droit; 4 =  cordon medullaire 
gauche; 5 =  eperon osseux.
importante au niveau de la region lombo- 
sacree. On constate a ce niveau une deforma­
tion des corps vertebraux qui sont hypotrophies 
et un amincissement important des lames et 
des pedicules vertebraux. L’axe principal de 
la cavite lombo-sacree semble oriente vers la 
gauche, probablement en rapport avec une 
meningocele. Une myelographie gazeuse (Figs. 
5 et 6) permit de noter une diplomyelie carac- 
terisee par une division de la moelle en deux 
cordons nettement objectives, jusqu’au segment 
terminal lombo-sacre (Fig. 5a). Au niveau de 
L3, il a ete mis en evidence, grace a la tomo- 
graphie, un eperon osseux qui semble etre en 
rapport plus etroit avec le cordon medullaire 
lateral droit (Fig. 5b).
A ^intervention chirurgicale, il a ete pos­
sible de verifier l’existence de l’eperon osseux 
qui est responsable d’une division du canal 
lombo-sacre en deux cavites contenant chacune 
un cordon medullaire.
D iscussion
Une premiere consideration qui s’impose, 
d ’apres l’analyse de ces deux cas rapportes, 
est que la myelographie gazeuse a permis 
d’etudier avec beaucoup de precision les 
caracteristiques de la malformation de la 
moelle. Une telle etude n ’a jamais ete rap-
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Fig. 7.—Cas 2. En projection sagittale, la 
moelle apparait aplatie au niveau on elle se 
trouve partiellement separee (fleches): plus bas, 
on distingue 1’image du cordon medullaire droit, 
qu’on peut suivre jusqu’au-dessous de l’eperon.
portee a notre connaissance. La separation 
de la moelle dans les deux cordons lateraux 
y est nettement objective et, fait remar- 
quable, elle semble s’effectuer dans les deux 
cas au niveau des derniers segments thora- 
ciques, en contraste avec la position de 
l’eperon osseux ou osteo-fibreux, qui semble 
se trouver beaucoup plus bas, au niveau 
des premiers segments lombaires.
Grace a la myelographie gazeuse, il a 
ete aussi possible de bien definir le diametre 
de la moelle. Dans le premier cas, nous 
avons ainsi pu evaluer l’epaisseur des deux 
cordons issus de la division medullaire et 
du cordon lateral droit au-dessous de cet 
eperon (jusqu’a son segment terminal). Dans 
le deuxieme cas, nous avons note des varia­
tions de calibre importantes, notamment, 
de la portion proximale des deux cordons 
(bien au-dessus de l’eperon), qui a ce niveau 
semblent encore partiellement unis en pro­
jection antero-posterieure et aplatis en pro­
jection laterale (Fig. 7).
La tomographie en projection antero- 
posterieure s’avere particulierement interes- 
sante dans cette etude myelographique. Dans 
le cas 1, en effet, l’espace sous-arachnoidien 
lombo-sacre n’est pas bien visualise du
cote gauche autour du cordon medullaire 
et celui-ci, de ce fait, est mal definissable. 
En demontrant ainsi l’accolement d’une par- 
tie des structures medullaires a la paroi 
d’une meningocele, deja operee, correspon- 
dant au deficit moteur homolateral presque 
complet, la myelographie a aide dans ce 
cas a la decision du rejet de toute interven­
tion chirurgicale. Dans le deuxieme cas, 
les deux cordons medullaires sont, par 
contre, bien definissables dans leur ensem­
ble et, leur direction au-dessous de l’eperon 
osseux peut etre suivie avec beaucoup de 
precision jusqu’a l’ouverture osseuse de la 
meningocele sacree, ou ils semblent se con- 
fondre avec une masse informe.
Enfin, grace a la tomographie de pre­
cision due a 1’emploi du mouvement hypo- 
cycloi'dal, certains rapports de la moelle 
avec les anomalies osseuses sont identifies 
dans tous leurs details. Ainsi dans le pre­
mier cas, il nous a ete utile d’objectiver 
l’endroit ou l’adherence du segment terminal 
du cordon medullaire droit s’etait etabli 
egalement en rapport avec la paroi poste- 
rieure du canal rachidien, et la direction 
des racines issues de ce cordon. Dans le 
deuxieme cas, outre 1’epaisseur importante 
du tissu fibreux extra-dural, notee au ni­
veau de la paroi droite de la cavite lombo- 
sacree (qui apparait reguliere), il nous a 
ete possible de mettre en evidence le contact 
etroit du cordon medullaire droit pres de 
l’eperon osseux et meme sa reduction de 
calibre au niveau de ce contact.
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Overcome this problem in hospital treatment of surgical infections, osteomyelitis 
and other serious infections.
A GOOD SOLUTION
Lincocin
Lincocin is effective against virtually all types of staphylococci including both peni­
cillinase and non-penicillinase-producing strains.
Sensitivity of Staph, aureus to Lincocin1 
7516 Strains Tested
7065-94% sensitive
451-6%  resistant
“...if one examines the total number of strains of S. aureus tested in vitro for ac­
tivity of lincomycin we find that 7516 strains have been tested and reported. Of the 
7516 strains, where data is available, 7065 (94 percent) reported as sensitive and 
only 451 (6 percent) reported as resistant. For any antibiotic which has been avail­
able since 1962, this is a fairly impressive record.”
1. Herrell, W.E., Lincomycin. (1969). Mod. Sc ien tific  Publ.,Chi., p. 28.
732 TRADEMARKS: POLYSAL, POLYSAL M-CUTTER; PYOPEN, ORBENIN, PENBRITIN-AYERST; CEPORAN-GLAXO-ALLENBURY5; KEFLIN-LILLY; CHLOROMYCETIN-PARKE DAVIS; STAPHCILLIN- 
BRISTOL; TERRAMYCIN - PFIZER; ACH ROMYC IN-LEDERLE REGISTERED TRADEMARKS: LINCOCIN, SOLU-CORTEF, MEDROL TRADEMARKS: SOLU-MEOROL, MIX-O-VIAL CE 6707.2
Upjohn THE UPJOHN COMPANY OF CAN AD A/DO N  MILLS, ONTARIO
•A
Lincocin Sterile Solution Compatibilities with I.V. Solutions
Lincocin (600 mg -  2 ml and 1800 mg -  6 ml) was found to be physically compatible with 
500 ml of the following solutions for a period of 24 hours at room temperature.
5% Dextrose in Water 10% Dextrose in Saline Ringer’s Solution
5% Dextrose in Saline Invert Sugar 10% Sodium Lactate 14 Molar
10% Dextrose in Water Polysal Travert 10% Electrolyte No. 1*
Polysal M with 5% Dextrose
^Compatibility was determined by a study which indicated no appreciable change in the pH of the resultant mixture and no loss of 
potency of the lincomycin when diluted as indicated above.
Compatibilities Of Lincocin With Other Injectable Preparations In Infusion Solutions 
For A Period Of 24 Hours At Room Temperature
Where indicated,compatibility studies have been made using the trademarked products speci­
fied. Other branded products, although generically similar, may employ different formulas, and 
may not be compatible with Lincocin. The information reported is obtained with products on 
sale in Canada, and refers to physical compatibility and not biological activity.
D rug Q uantity In fu s io n  S o lu tio n
C o m p a tib ility  
with 2 ml 
S .S . L in c o c in  
6 0 0  m g
C o m p a t ib ilit y  
w ith 6  m l 
S .S .  L in c o c in  
1 8 0 0  m g
C a r b e n ic ill in  (P yopen) 2 g D e x tro se  5 % ,  5 0 0  m l S a t is fa c to ry S a t is f a c t o r y
C e p h a lo r id in e  (C e p o ran ) 2 5 0  m g D e x tro s e  5 % ,  5 0 0  m l S a t is fa c to ry S a t is f a c t o r y
C e p h a lo th in  S o d iu m  (K e flin ) 1 g D e x tro se  5 % ,  5 0 0  m l S a t is fa c to ry S a t is f a c t o r y
C h lo ra m p h e n ico l S o d iu m  S u c c in a te 1 g D e x tro se  5 % ,  5 0 0  m l S a t is fa c to ry N o t d e te rm in e d
(C h lo ro m y ce tin ) 
C lo x a c i ll in  (O rbenin) 2 5 0  m g D e x tro se  5 % ,  5 0 0  m l S a t is fa c to ry N o t d e te rm in e d
H y d ro co rt iso n e  I .V .(S o lu -C o r te f  M .O.V.) 1 0 0  m g D e x tro se  5 % ,  5 0 0  m l S a t is fa c to ry N o t d e te rm in e d
H y d ro co rt iso n e  I.V . (S o lu -C o rte f  M .O.V.) 2 5 0  m g D e x tro se  5 % ,  5 0 0  ml S a t is fa c to ry N o t d e te rm in e d
H y d ro co rt iso n e  I.V . (S o lu -C o rte f  M .O.V.) 5 0 0  m g D e x tro se  5 % ,  5 0 0  m l S a t is fa c to ry N o t d e te rm in e d
H y d ro co rtiso n e  I.V . (S o lu -C o rte f M .O.V.) 1 g D e x tro se  5 % ,  5 0 0  m l S a t is fa c to ry S a t is f a c t o r y
M e th ic il lin  S o d iu m  (S ta p h c ill in ) 1 g D e xtro se  5 % ,  5 0 0  m l S a t is fa c to ry S a t is f a c t o r y
M e th y lp re d n iso lo n e  I.V . (S o lu -M ed ro l M .O.V.) 4 0  m g D e x tro s e  5 % ,  5 0 0  m l S a t is fa c to ry N o t d e te rm in e d
M e th y lp re d n iso lo n e  I.V .(S o lu -M e d ro l M .O.V.) 1 2 5  m g D e x tro se  5 % ,  5 0 0  m l S a t is fa c to ry N o t d e te rm in e d
M e th y lp re d n iso lo n e  I.V .(S o lu -M e d ro l M .O.V.) 5 0 0  m g D e xtro se  5 % ,  5 0 0  m l S a t is fa c to ry N o t d e te rm in e d
M e th y lp re d n iso lo n e  1 .V. (S o lu -M ed ro l) 1 g D e x tro se  5 % ,  5 0 0  m l S a t is fa c to ry S a t is f a c t o r y
O x y te tra c y c lin e  H C I (T e rra m y c in  I.V .) 0 .5  g D e x tro se  5 % ,  5 0 0  m l S a t is fa c to ry S a t is f a c t o r y
P e n ic i ll in  G P o ta ss iu m 5 0 0 ,0 0 0 D e x tro se  5 % ,  5 0 0  m l S a t is fa c to ry N o t d e te rm in e d
(P e n ic i ll in  G, A y e rst) 
P e n ic i l l in  G P o ta ss iu m
U n its  
1 m illio n D e x tro s e  5 % ,  5 0 0  m l S a t is fa c to ry N o t d e te rm in e d
(P e n ic i ll in  G, A y e rst) 
S o d iu m  A m p ic il lin  (P e n b rit in )
U n its  
5 0 0  m g D e x tro se  5 % ,  5 0 0  ml S a t is fa c to ry S a t is f a c t o r y
T e tr a c y c lin e  H CI (A ch ro m yc in ) 0 .5  g D e xtro se  5 % ,  5 0 0  ml S a t is fa c to ry N o t d e te rm in e d
Lincocin prescribing information
Indications: Infections caused by Gram-positive organisms which are susceptible to the action of Lincocin, particularly staphylococci 
(including penicillinase-producing staphylococci), streptococci, and pneumococci. Not active against Streptococcus faecalis, yeasts, or 
Gram-negative organisms including N. gonorrhceae and H. influenzae.
DOSAGE AND ADMINISTRATION 
Lincocin Sterile Solution:
Intramuscular
Adults 600 mg (2 ml)
Mild every 24 hours
Severe 600 mg (2 ml)
every 12 hours
Children** 5 mg/lb every
Mild 24 hours
Severe 5 mg/lb every
12 hours
Intravenous
600 mg (2 ml) 
every 8-12 hours*
600-2100 mg (2-7 ml) 
every 8-12 hours*
5-10 mg/lb/day in two to three 
doses at 8-12 hour intervals.* 
For severe infections these 
doses may have to be increased.
*Lincocin should be added to 250 ml or more of 5 %  glucose in 
water or normal saline and given as an infusion over a period of 
30-120 minutes. When doses of 4 grams or more are given Linco­
cin should be diluted in 500 ml of fluid and administered at a rate 
not to exceed 100 ml/hour. Doses as high as 8.4 grams per day 
for 7 days in four divided doses of 2100 mg in an infusion of 250 
ml of normal saline over a period of 120 minutes were well toler­
ated in normal volunteers.
**Over one month of age.
Cautions: Generally well tolerated. With oral administration, gastrointestinal side effects have been encountered such as loose stools or 
diarrhoea, nausea, vomiting, and abdominal cramps. Other minor side effects have been observed infrequently. Side effects such as neu­
tropenia, leukopenia, agranulocytosis and hypersensitivity reactions have been observed on rare occasions. Should not be used in patients 
sensitive to clindamycin.
Pending further clinical experience, Lincocin is not recommended in the newborn, in the prophylaxis of a recurrence of rheumatic fever, 
and in patients with pre-existing kidney, liver, endocrine, or metabolic diseases. Since safe conditions for the parenteral use of Lincocin 
in pregnancy have not been established, its use in such patients should involve careful consideration of expected benefits and possible 
risks. Detailed information is available on request.
Lincocin Sterile Solution: Each ml contains lincomycin hydrochloride equivalent to 300 mg lincomycin base, in 2 ml and 10 ml vials.
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SCANNING ELECTRON MICROSCOPIC STUDIES OF THE HIP JOINT 
CAPSULE AND SYNOVIAL MEMBRANE*
HUGH U. CAMERON. M.B., Ch.B.t and IAN MACNAB, M.B., Ch.B., 
F.R.C.S.[Eng. & C],t 
Toronto, Ont.
Summary: A study of the synovial membrane 
and the capsule of the hip joint by scan­
ning electron microscopy has revealed sig­
nificant differences between the normal and 
osteoarthritic hip. The changes that develop in 
osteoarthritis cannot be seen by light micro­
scopy and are not revealed by the transmis­
sion electron microscope because of lack of 
three-dimensional visualization. Although it is 
impossible at present to explain adequately the 
pathogenesis of these changes, light may be 
cast on this problem by further studies using 
this method of examination.
Resume: L'etude de la synoviale et de la capsule 
de I'articulation coxofemorale par microscope 
electronique a scintillation a revele d'impor- 
tantes differences entre une articulation nor­
mals et une articulation frappee d'osteo-arthrite. 
Les modifications provoquees par cette patho- 
logie ne peuvent etre mises en evidence par 
le microscope classique et ne peuvent pas 
etre revelees non plus par le microscope elec­
tronique a transmission selective, parce que les 
details de I'image ne sont pas vus en trois 
dimensions. Bien qu'il soit actuellement impos­
sible de donner une explication valable de la 
pathogenie de ces modifications, de nouvelles 
etudes effectuees par cette methode originale 
permettront sans doute de jeter une lumiere 
nouvelle sur ce probleme.
The scanning electron microscope is a 
relatively new tool which has not hitherto 
been applied to the study of the synovial 
membrane or the fibrous capsule of joints. 
This paper reports significant changes ob­
served in the ultrastructure of the capsule 
and synovial membrane of the hip in osteo­
arthritis using the scanning electron micro­
scope. A narrow beam of electrons is 
directed at the specimen and scanned very 
rapidly across the surface. Both reflected 
and secondary emissions are collected, the 
signal is amplified and is then transformed
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Toronto.
into a picture on a cathode ray screen. 
Great depth of field and significant contrast 
are obtained. Because the surface of the 
specimen has to be electrically conductive 
most biological materials need to be coated 
with a conducting agent.
M aterials and  M ethods
Six specimens of the synovial membrane 
and capsule from each of 15 normal hip 
joints were examined. The findings were 
compared with those from the same number 
of samples taken from each of 25 hip 
joints which were the site of osteoarthritis 
of sufficient severity to warrant total hip 
replacement.
The specimens were prepared by freez­
ing immediately after excision at operation 
or autopsy. Freeze drying was then carried 
out with the use of a Thermovac lyophylizer, 
and specimens XA  x 14 inch were cut from 
the main block of tissue with a sharp scalpel. 
The specimens were mounted on aluminum 
stubs with DAG 416 epoxy resin conduc­
tive adhesive and received a fine surface 
coating of gold by evaporation. Minor 
morphologic changes are produced in the 
tissue by the preparation process. However, 
since all specimens are prepared in the 
same way, the observed differences would 
seem to be significant.
R esults
Normal Synovium
This shows a wavy, irregular appearance, 
like water running through rapids. At a 
higher magnification the irregularity is seen 
to be produced by bulges of synovium with 
collagen fascicles running between them. 
At higher magnification many tiny pro­
jections are evident on the surface. These 
probably correspond to the filopodia of 
the A cells described by the transmission 
electron microscopists.1 In some areas the 
surface presents an open network. At still 
higher magnification it can be seen that 
these are zones of sessile villi.
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Fig. 1.—Normal synovial membrane. The sy­
novial membrane presents an irregular surface. 
Numerous pores (ringed in white) can be seen. 
They present the appearance of volcanic craters 
(x 1,000).
A profusion of pores exists whose sizes 
are of the order of 10‘5 to 10‘6 cm. (Fig. 1). 
These pores may have both a secretory and 
an absorptive function. Their presence ex­
plains the ability of synovial membrane to 
absorb relatively large particles artificially 
introduced into joints in vivo.2 The existence 
of these pores would suggest that a base­
ment membrane must be present as in the 
kidney. A basement membrane was de­
scribed by Langer and Huth3 but was not 
identified by subsequent investigators.4 
Barland, Novikoff and Hamerman1 describ­
ed an amorphous granular layer on which 
the synovial intimal cells lie but did not 
interpret this as a basement membrane. 
It seems possible, however, in view of dif­
ferential diffusion into synovial cavities and 
the presence of pores, that a functioning 
basement membrane does indeed exist.
Normal Fibrous Capsule
This consists of regularly arranged sheets 
or rafts of collagen. When the capsule is 
cut in the direction of the fibre bundles,
Fig. 2.—Normal capsule. Note the orderly ar­
rangement of the collagen fascicles running in 
parallel bundles (x 2,300).
the actual fibres can be seen to be laid 
down parallel to each other (Fig. 2). When 
the cut is made at right angles to the pre­
dominant direction, thick collagenous slabs 
are evident. The regular arrangement of 
the fibre bundles is most striking.
Osteoarthritis
Examination by light microscopy reveals 
little qualitative difference in the appearance 
of the synovial membrane and capsule in 
osteoarthritis and in normal joints. The 
fibrous capsule is thicker and the synovium 
tends to show more villi. However, the scan­
ning electron microscope shows gross dif­
ferences between normal and osteoarthritic 
joints in the appearance of the synovial 
membrane and capsule.
Synovium .—The synovium looks like a 
flat, desert waste (Fig. 3). The filopodia are 
much smaller than normal and indeed, in 
a few specimens no filopodia can be seen. 
Pores are very much in evidence and are 
similar in size to those of normal synovium. 
It is known that permeability of the blood/ 
synovial barrier increases in acute inflam-
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Fig. 3.—Synovial membrane in osteoarthritis. The
normal rippling appearance is lost and at this level 
of magnification the synovial membrane takes 
on the appearance of gentle undulating folds 
(x 100).
mation but the effect of chronic inflamma­
tion is variable.5 The similarity in pore 
size between normal and osteoarthritic sy­
novial membranes would seem to indicate 
that there is no substantial increase in per­
meability. The villi are much larger than 
those seen in normal synovium.
In some areas fibrous strands are visible 
on the surface (Fig. 4). Occasionally strange 
projections are seen on the surface which 
are absent in normal synovium; these may 
be pacinian corpuscles.
Peculiar rod-like structures are occa­
sionally seen on the surface which are never 
present in normal synovium. We were un­
able to determine the exact nature of these 
structures. They may represent the “col­
lagen” fibres in contact with joint spaces 
described by Coulter.6
Fibrous capsule.— Scanning electron mi­
croscopic studies of the fibrous capsule 
reveal the ravages of the disease not shown
Fig. 4.—In osteoarthritis the synovial membrane 
frequently shows fibrous strands on the surface 
(x 220). '
by light microscopy. The normal, smooth, 
orderly arrangement of collagen fibres is 
lost (Fig. 5) and replaced by a jumbled 
mass like a tangled skein of wool. There 
are always a few focal patches of relatively 
normal-looking capsule, but they are re­
latively few.
D iscussion
The atrophy of the synovial membrane in 
osteoarthritis suggests that it is affected by 
a primary destructive process. Cell death 
resulting from such a lesion would mean 
the release of the contained lysosomes into 
the synovial fluid. It has been shown by 
Ali7 that autolytic degradation of cartilage 
can occur through the action of an acid 
protease —  cathepsin. This is capable of 
depolymerizing chondromucoprotein.8 Ca­
thepsin released from the synovial membrane 
into the synovial fluid would explain why 
metachromasia is absent in the superficial 
zone of the articular cartilage in osteo-
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Fig. 5a Fig. 5b
Fig. 5.—(a and b) Fibrous capsule of the hip joint in osteoarthritis. The regular orientation of 
the rafts of collagen fascicles has been lost and they present a jumbled tangled skein of fibres 
(a x 108, b x 1,000).
arthritis, since loss of metachromasia is a 
measure of the depolymerization of chon- 
dromucoprotein.
The decrease in surface area of the sy­
novial membrane due to stunting or loss 
of filopodia may reduce the secretion of 
the active lubrication elements into the 
synovial fluid. When synovial fluid is no 
longer thixotropic a failure of elastohydro- 
dynamic lubrication must occur.9 It is pos­
sible that a primary lesion of the synovial 
membrane could initiate and later accelerate 
cartilage breakdown.
One of the most striking changes seen in 
the course of this investigation was that the 
collagen fibres took on the appearance of a 
jumbled mass like a tangled skein of wool. 
Normally, in tendons and in the capsule of
joints, collagen is laid down along lines of 
tension. There are three possible explana­
tions for this lack of orientation: (1) In 
osteoarthritis there is no predominant uni­
directional tension and the capsule of the 
joint is subjected to strain in all directions. 
(2) The jumbled mass may represent new 
collagen being rapidly formed as in a heal­
ing wound. However, in a healing wound it 
is only the tropocollagen that forms in a 
tangled mass. With organization of a scar 
the collagen takes the direction of lines of 
stress. It is unlikely that in osteoarthritis of 
the hip joint collagen is continuously being 
reformed throughout the whole process. (3) 
In tissue culture, collagen fibres will form an 
orderly arrangement of fascicles unless the 
matrix has been interfered with, when their
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arrangement becomes disorganized. The 
most likely explanation for this jumbled 
arrangement in the capsule of the osteo- 
arthritic hip is an alteration in the muco­
polysaccharide ground substance. As a 
result of this breakdown in the ground 
substance it is impossible for the collagen 
fibres to be organized into regular lines 
of orientation.
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STENOSIS OF THE COLON DUE TO PANCREATITIS AND 
MIMICKING CARCINOMA*
R. J. HANCOCK, R. M. CHRISTENSEN, M .D .,f T. R. OSLER, M .D.f
and M. M. CASSIM, M.B.,§ Vancouver, B.C.
Summary: Stenosing lesions of the colon are an 
uncommon and confusing sequel to pancreatitis. 
Five cases are presented and the literature on 
the subject is reviewed. Some cases cannot 
be differentiated radiologically from carcinoma. 
The history, enzyme studies and location of 
the stenosis in the left colon may alert the 
clinician to this rare diagnosis. The ideal treat­
ment should be non-operative or at least a 
conservative operation, since these lesions 
commonly resolve spontaneously.
Resume: Les lesions stenosantes du colon 
constituent une rare sequelle de la pancreatite, 
mais elles peuvent preter a confusion. Les 
auteurs en presentent cinq cas et passent en 
revue la litterature pertinente. Les examens ra- 
diologiques ne permettent pas, en certains cas, 
de differencier ces lesions d'une tumeur cance- 
reuse. L'histoire clinique, les etudes enzyma- 
tiques et la localisation de la stenose au niveau 
du colon gauche permettent de mettre le cli- 
nicien sur la voie de ce rare diagnostic. Le 
traitement ideal ne devrait pas etre operatoire 
ou, du moins, ne devrait comporter qu'une ope­
ration conservatrice, car ces lesions ont ten­
dance a entrer en resolution spontanement.
Pancreatitis is a bizarre and puzzling 
disease. Both internists and surgeons know 
that its manifestations and complications 
may be variable and challenging. Inflam­
matory disease of the pancreas can affect 
many organs and systems in the body— 
neuropsychiatric, metabolic, pulmonary, hep­
atobiliary and gastrointestinal. Adjacent 
organs such as the stomach or duodenum 
are commonly involved in the acute or late 
stages of the disease. Although colonic
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sequelae have been considered to be rare, 
we have collected five such cases seen in 
the past 1V2 years at the Vancouver General 
Hospital.
Pancreatitis may produce stenosis, hemor­
rhage, fistula, gangrene or perforation of 
the colon.1 4 These complications seldom 
receive allusion in the literature or even in 
textbooks devoted to pancreatic disease, al­
though all are discussed in the text of How­
ard and Jordan.3 In 1927 Forlini5 re­
ported a case in which the fatal outcome 
was due to colonic obstruction. Mohiuddin 
et al.4 in a recent review found only 10 
reported cases; they added two more, both 
lesions of the splenic flexure mimicking 
carcinoma. One patient had left hemicolec­
tomy (the operative diagnosis was perforat­
ing carcinoma) and the other was managed 
without operation because the histopathology 
of the first case had proved benign. Both 
patients recovered. A number of other 
workers have reported cases6- 7 (Table I). 
The age of those affected is variable but the 
condition is seldom seen in the very young. 
The sex distribution is predominantly male. 
The usual area affected is the splenic 
flexure, but the transverse, descending and 
even the right colon have been involved.2
Our five patients all had stenotic lesions 
of the colon, most of them indistinguishable 
radiologically from carcinoma and all due 
to pancreatitis. None was diagnosed pre- 
operatively and even at operation two were 
misdiagnosed! Two were encountered on a 
single ward within three months.
Case Reports
Case 1.—This 35-year-old man saw his doc­
tor in May 1969 because of a two-month his­
tory of steady mid-abdominal pain and nausea. 
This pain was not associated with food inges­
tion but the patient was a fairly heavy drinker. 
Complete gastrointestinal radiography and 
peripheral blood findings at this time were 
normal. Four months later the patient was 
admitted to hospital with persistent lower ab­
dominal pain and alternating diarrhea and con-
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TABLE I.—D etails of R eported Cases of Stenosis of the Colon Following Pancreatitis
Age tf
patient
Author (years) Site Treatment Results
Forlini 19275 38 Splenic flexure
(autopsy finding)
Remington, Mayo and
Splenic flexure Colon resectionDockerty 19471- 44 Alive and well
45 Splenic flexure Colon resection Recurring pancreatitis
Miln and Barclay 19526 71 Splenic flexure Resection Alive and well
73 Splenic flexure Colostomy Alive and well
Schwartz and
Nadelhaft 1957s 68 Splenic flexure Cecostomy Alive and well
76 Snlenic flexure Cecostomy Alive and well
30 S rleiic flexure Laparotomy Alive and well
Howard and 
Jordan 19S03 63 Transverse colon at 
2 sites Resection Alive and well
Lukash 19672 21 Hepatic flexure Laparotomy and 
biopsy Alive and well
Mohiuddin et al. 19714 44 S denic flexure Resection Alive and well
63 S denic flexure No operation Alive and well
Hancock et al. 1973 35 Descending colon Cecosigmoidoscopy Alive and well
36 Descending colon 
Hepatic flexure
Laparotomy and 
biopsy Recurring pancreatitis
65 Laparotomy, lavage Fecal fistula and
and drainage death
61 Splenic flexure Laparotomy and Laparotomy 13 mos.
biopsy later showed carci­
noma of pancreas 
— colon normal
54 Splenic flexure Colostomy Alive and well
Fig. 1.—Case 1. A stenotic lesion of the descend­
ing colon is illustrated. At operation this was 
thought to be an inoperable neoplasm and a by­
pass was done.
stipation. He looked ill and had lost 25 lbs. in 
weight. There were tenderness and guarding 
in the left upper quadrant. Again the results 
of routine blood investigation were normal but 
the serum amylase was not determined. A 
barium enema showed a constricting lesion in 
the descending colon (Fig. 1). At operation a 
large firm mass was found in the retroperi­
toneal space involving the pancreas and sur­
rounding the left colon. The surgeon diagnosed 
an inoperable neoplasm and performed a ce- 
cosigmoidostomy as a bypass. The biopsy 
showed inflammation and fat necrosis. The 
patient made a good recovery but five weeks 
after operation he was readmitted with upper 
abdominal pain, nausea and vomiting, and an 
elevated serum amylase of 512 Somogyi units/ 
100 ml. The condition settled with conserva­
tive treatment. Two barium enemas done over 
the next six months showed first improvement 
and then resolution of the stenosis (Fig. 2).
Case 2 .-—A  36-year-old white man was ad­
mitted in November 1969 because of a history 
of indigestion, nausea and vomiting for six 
months. He was a known alcoholic. A barium 
meal showed a duodenal ulcer and some scar­
ring. Because of anemia (hemoglobin 10 g ./
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Fig. 2.—Case 1. Partial resolution of the lesion 
seen in Fig. 1, six months later. Mucosal ir­
regularity is still present.
100 ml.) and weight loss, a barium enema was 
done. This showed a constricting lesion in the 
descending colon, diagnosed by the radiologist 
as carcinoma (Fig. 3). Amylase studies were
Fig. 3.—Case 2. Lesion of the descending colon 
mimicking carcinoma.
Fig. 4.—Case 3. A barium enema showing the 
constricting lesion at the hepatic flexure.
not done. At laparotomy a large inflammatory 
mass involving the pancreas and left colon 
was found. The colon was freed from the mass 
but no intrinsic lesion was discovered. The 
biopsy showed fat necrosis only. The patient 
made a good recovery but has been readmitted 
to hospital several times since with a clinical 
picture of pancreatitis and raised serum amy­
lase.
Case 3 .—A 65-year-old white man was 
admitted in November 1969 because of the 
sudden onset of crampy abdominal pain ag­
gravated by food intake. He had had an ap­
pendectomy years before and a cholecystec­
tomy for cholecystitis and cholelithiasis in 
1965. The pain subsided in about a week but 
upper abdominal discomfort persisted. On ini­
tial examination he looked quite ill with a pulse 
of 120/min., blood pressure of 125/70 mm. 
Hg and a temperature of 39° C. The abdomen 
was markedly distended and there was a pal­
pable tender mass, 10 cm. in diameter, in the 
right upper quadrant. No jaundice was evident 
but the serum bilirubin ranged from 1.8 to 
2.8 m g./100 ml., the alkaline phosphatase 
was normal and the serum proteins slightly 
decreased with a reversal of the albumin- 
globulin ratio. No pancreatic enzyme studies 
were done. Investigations included intravenous 
pyelogram, intravenous cholangiogram, cysto- 
grarn and retrograde pyelogram— all were nor­
mal. A barium enema showed depression of
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the hepatic flexure and marked constriction 
of the colon (Fig. 4). There were no signs of 
obstruction and this confirmed the clinical 
diagnosis of an extrinsic lesion such as retro­
peritoneal sarcoma.
At laparotomy on December 4, 1969, ob­
vious acute suppurative pancreatitis was found. 
A huge retroperitoneal mass in the upper ab­
domen surrounding the right colon made iden­
tification of structures difficult. A considerable 
volume of old blood, pus and pancreatic tissue 
was evacuated, the area was lavaged with saline 
and multiple sump drains were inserted. 
Postoperatively the patient developed a fecal 
fistula, there were multiple hemorrhages and 
his condition steadily deteriorated until his 
death 15 days later. Autopsy revealed com­
plete destruction of the pancreas due to necro­
tizing and hemorrhagic pancreatitis with in­
volvement of the right colon.
Case 4 .—A 61-year-old man presented in 
September 1970 with a two-month history of 
crampy, intermittent, abdominal pain in the 
left upper quadrant. This was unrelated to food 
ingestion, but he was a heavy drinker. His 
weight had been steady and his bowel habit 
normal. Physical examination including sig­
moidoscopy disclosed no abnormality; the 
results of peripheral blood investigation were 
normal. Amylase and lipase estimations were 
not done. A barium enema showed a constrict­
ing lesion of the splenic flexure, diagnosed as 
carcinoma (Fig. 5). At laparotomy the pan­
creas was diffusely enlarged, firm and nodular. 
The splenic flexure was involved in a mass of
Fig. 5.—Case 4. Barium study showing a stenos- 
ing lesion with the classical appearance of a 
carcinoma.
Fig. 6.—Case 4. Repeat barium enema showing 
resolution of the lesion illustrated in Fig. 5.
inflamed fat contiguous with the pancreas but 
extrinsic to the colon. The presumptive diag­
nosis was pancreatitis, and biopsy showed fat 
necrosis. TTie patient made an uneventful re­
covery and a repeat barium enema done in 
January 1971 showed resolution of the stenosis 
(Fig. 6). The patient was re-explored in Octo­
ber 1971 and found to have carcinoma of the 
pancreas with carcinomatosis. The left colon 
showed no stenosis at that time.
Case 5 .—This 54-year-old man was ad­
mitted to hospital in October 1971 with a his­
tory of increasing abdominal pain, distension 
and obstipation of four days’ duration. There 
was no nausea or vomiting, change in previous 
bowel habit, or weight loss. Four years pre­
viously he had been admitted with ascites 
and he had a history of chronic alcoholism. 
The positive findings, apart from a tachycardia 
of 100/min., were confined to the abdomen. 
This was diffusely distended and tympanitic. 
There was no ascites. The hemoglobin was 14 
g./'lOO ml. and the leukocyte count was 12,- 
500/c.mm. with a shift to the left. Sigmoido­
scopy was normal. No pancreatic enzyme stu­
dies were done. Abdominal x-rays suggested 
colonic obstruction at the splenic flexure (Fig. 
7). Nasogastric suction was started and intra­
venous therapy was given. A barium enema 
revealed a sharply defined lesion at the splenic 
flexure diagnosed as carcinoma (Fig. 8).
A right transverse colostomy was done that 
same day with a presumptive diagnosis of ob-
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Fig. 7.—Case 5. Abdominal x-ray showing large bowel obstruction.
structing carcinoma; the abdomen was not 
explored. He had a prolonged ileus postopera- 
tively but made a good recovery. Three weeks 
later a left colon resection was planned but at 
operation the pancreas was found to be en­
larged and the body and tail acutely inflamed. 
There were hemorrhagic areas and fat necrosis 
in the gastrocolic ligament and splenic flexure. 
The latter was mobilized but no intrinsic lesion 
of the colon was found. A  cholecystostomy and 
T-tube drainage of the common bile duct were 
done. No stones were present in the gallblad­
der or common bile duct. The postoperative 
course was satisfactory and the patient has now 
had the colostomy successfully closed.
D iscussion
As far as we can determine this is the 
largest series of such cases recorded. The 
fact that five cases were seen over a 2V?.- 
year period suggests that this lesion is more 
common than a study of the literature would 
indicate. The diagnosis is probably often 
missed. In none of these patients was the 
diagnosis made preoperatively; indeed, even 
at operation the diagnosis was difficult. The 
surgeon was usually puzzled, entertaining 
such diagnoses as tuberculosis and sarcoma 
when he found no intrinsic colonic lesion.
Radiologically the resemblance to carci­
noma is striking. We know of no way to dif-
Fig. 8.—Case 5. Barium enema showing a localized stenotic lesion at the splenic flexure.
ferentiate the condition from true carcinoma 
without surgical exploration. Stenosis of 
the colon appears to be associated with a 
subacute form of pancreatitis rather than 
with the acute hemorrhagic type. Seldom 
do these patients show the classical signs 
and symptoms of pancreatitis. Our ex­
perience suggests that this is a slowly pro­
gressive type of inflammation that gradually 
infiltrates the retroperitoneal space, result­
ing in edema, fat necrosis and a fibrotic 
stenosis which leads to stricture of the 
colon. Previous workers4- 8 have described 
the peripancreatic anatomy that would ap­
pear to favour this process. The head and 
proximal body of the pancreas are closely 
adjacent to the transverse colon and meso­
colon and the visceral peritoneal layers are 
contiguous. The distal body and tail are
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adjacent to the splenic flexure, and the 
phrenicolienal ligament with its peritoneal 
layers is common to both. Presumably if 
this process were more acute or lytic, or 
if it communicated with a pancreatic duct, 
the classical pseudocyst would form.
In contrast to colonic fistulas of similar 
etiology3’ 9 the natural course of this con­
dition would seem to be benign, as il­
lustrated by our cases and those in the 
literature. A history of upper abdominal 
symptoms suggestive of pancreatitis should 
alert the clinician to have amylase or lipase 
studies done. These are often omitted. The 
location of the lesion is often at the splenic 
flexure or adjacent transverse or descending 
colon as demonstrated in four of our five 
cases. However, as in Case 3 and that re­
ported by Lukash,2 this weird process may 
involve the right colon. Most of these pa­
tients are heavy drinkers or alcoholics, 
which throws light on the etiology of the 
pancreatitis, and such a history may arouse 
the clinician’s suspicion.
Baylin and Weeks10 described mucosal 
irregularities which may possibly be present 
in Cases 1 and 4 (Figs. 2 and 7). The colon 
“cut off sign” described by Stuart11 and 
illustrated by Case 5 may be valuable, but 
unfortunately a classical “apple-core lesion” 
was present also, favouring a diagnosis of 
more definite mechanical obstruction.
Such a small series does not permit a 
dogmatic statement regarding treatment. If 
a preoperative diagnosis is possible the pre­
ferred treatment is conservative, as in 
Mohiuddin's ' second case. Acute obstruc­
tion (as in our Case 5 and as described by 
Rose7) should be managed according to 
accepted surgical principles, as also should 
chronic obstruction (e.g. Case 1). Opera­
tion is performed in most cases because 
of barium enema findings suggesting car­
cinoma and, as discussed above, laparotomy 
may be the only course open. If he finds 
no intrinsic lesion the surgeon should
seriously consider a diagnosis of stenosis 
of the colon, in which case he should take 
a biopsy and close the abdomen. In Case 
1 a bypass was done because the surgeon 
thought he was dealing with an inoperable 
extrinsic tumour and increasing obstruction. 
Extensive dissection is probably unwise and 
predisposes to fistula with its high mortal­
ity9 as in Case 3. Resection imposes un­
necessary risk in most cases. If acute pan­
creatitis is present or if pancreatitis is 
feared postoperatively, we advise sump 
drainage of the affected area as well as 
biliary drainage; gastrostomy and jejunos- 
tomy may be indicated.
The authors wish to thank Drs. D. B. Allardyce, 
R. E. Robins and J. Stoller for the use of their 
case material.
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MORTALITY IN EMERGENCY RIGHT HEMICOLECTOMY*
HAILE T. DEBAS, M.D., F.R.C.S.[C] and FRANK B. THOMSON, M.D.. F.R.C.S.[C],
Vancouver, B.C.
Summary: The hospital records of 838 patients 
undergoing colectomy with anastomosis in a 
five-year period are reviewed. The operative 
mortality was 3% in 535 left colon resections 
and 6.4% in 249 right colon resections. The 
unexpectedly high mortality in right hemi­
colectomy was due to the death of 10 out of 
43 patients subjected to a one-stage emergency 
resection and anastomosis. The decision to 
perform resection with anastomosis in the face 
of established peritonitis was the single most 
important cause of death. Resection of the 
diseased bowel and establishment of a tem­
porary ileostomy with a colonic mucous fistula 
would prevent anastomotic breakdown.
Resume: Les auteurs passent en revue les dos­
siers hospitaliers de 838 malades ayant subi 
une colectomie avec anastomose durant une 
periode de cinq ans. La mortalite operatoire 
a ete de 3% des 535 cas de resection du colon 
gauche mais est montee a 6.4% des 249 cas de 
resection du colon droit. La forte mortalite de 
cette intervention, assez inattendue, s'explique 
par le deces de 10 des 43 patients ayant subi 
une operation d'urgence en un temps: resec­
tion et anastomose. La cause la plus impcrtante 
de ces deces doit etre trouvee dans la decision 
de pratiquer la resection d'urgence en presence 
d'une peritonite patente. La resection de la 
portion malade du colon et I'etablissement d'une 
ileostomie temporaire par fistule avec la mu- 
queuse du cdlon aurait pu prevenir la rupture 
de I'anastomose.
The operative mortality in 838 consecutive 
patients undergoing colectomy with anasto­
mosis at the Vancouver General Hospital 
in the five-year period 1964 to 1968 was 
4.9%. Of this total series, 535 patients had 
resection of their left colon with a mortality 
of 3.0%. We were surprised to find double 
this mortality (6.4%) in 249 patients sub­
jected to right hemicolectomy, a procedure 
we had presumed to be more benign. We 
were dismayed that of 43 patients who had 
emergency resection of their right colon,
’From the Department of Surgery, The Vancouver 
General Hospital and the Faculty of Medicine, 
University of British Columbia, Vancouver, B.C. 
Reprint requests to: Dr. H. T. Debas, Veterans’ 
Administration Centre, Building 115, Room 115, 
Los Angeles, California 90073, U.S.A.
10 (23%) died. The purpose of this article 
is to identify the cause of this high mortality 
and to propose changes in management by 
which we believe it will be reduced.
Woodhall and Ochsner in 1951,1 Gregg 
in 19552 and Madden in 19653 have all 
advocated that obstructing or perforating 
lesions of the colon be treated by primary 
resection and anastomosis. In 1957, Goligher 
and Smiddy4 showed that emergency 
resection and primary anastomosis was a 
safe treatment for obstructing carcinoma 
of the right colon. They also reported that 
of 52 patients with peritonitis from perforat­
ing carcinoma of the right colon treated by 
suture of perforation combined with cecos- 
tomy or colostomy 40 died, while of 21 in­
dividuals with a similar lesion treated by 
primary resection only five died.
This study will show that resection and 
primary anastomosis in the presence of 
peritonitis is hazardous.
Material and Methods
During the five-year period 1964 to 1968, 
838 patients underwent colectomy with an­
astomosis at the Vancouver General Hos­
pital. In 249 patients the operation was 
right hemicolectomy, performed as an elec­
tive procedure in 206 and as an emergency 
in 43 (Table I).
Elective colectomy implies that the bowel 
was mechanically prepared. In 90% of 
the patients undergoing elective operation 
the bowel was also bacteriologically pre­
pared with sulfonamides and/or neomycin. 
Emergency colectomy signifies resection of 
the unprepared bowel for obstruction, per­
foration, or gangrene.
Operative mortality is defined here as 
death from any cause within 30 days of 
operation, or at any time thereafter if the 
patient remains in hospital for complica­
tions related to the operation.
To evaluate the reason for the forbid­
dingly high mortality in emergency right 
hemicolectomy we considered the age of the 
patients, the presence of associated diseases 
in other systems, the pathological findings
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TABLE I —Colectomy With Anastomosis, Vancouver General Hospital 1964 to 1968. T he Percent­
age M ortality is G iven in Parentheses
All colectomies 
838 
(4.9%)
Right
249
(6.4%)
Left
535
(3%)
Other
54
Elective Emergency
206 43
(3%) (23%)
at operation, surgical technique and use of 
antibiotics.
R e s u l t s
Age
The average age of the patients under­
going emergency right hemicolectomy was 
59 years. This was not significantly dif­
ferent from the average age of the patients 
undergoing elective right colon resection 
(60.3 years). Those who died, however, had 
an average age of 67 years and four of the 
10 were older than 70 years.
Associated Diseases
One-quarter of the patients had inter­
current diseases such as chronic obstructive 
lung disease, atherosclerotic heart disease, 
cirrhosis of the liver, or diabetes mellitus. 
In only one patient, who died from myo­
cardial infarction, could death be directly 
attributed to the presence of an associated 
disease. The incidence of associated diseases 
was the same in both the elective and 
emergency right hemicolectomy groups.
Inadequate Preoperative Preparation
Our first reaction when we noted the 
high mortality in emergency right hemicolec­
tomy was to blame inadequate preoperative 
preparation of the patients. We looked for 
significant hypovolemia, electrolyte im­
balance and uncorrected anemia in the 43 
patients subjected to emergency operation.
Only two patients were operated upon in 
the presence of severe hypovolemia. Fluids 
and blood were rapidly administered to both 
miring induction of anesthesia and in the 
early intraoperative period. Neither of these 
died and both had adequate urinary output 
postoperatively. Serum electrolytes were de­
termined in only one-quarter of the patients. 
In all three in whom marked electrolyte dis­
turbance was found, this abnormality was 
corrected before operation. Two patients 
were operated upon with uncorrected ane­
mia, their hemoglobin levels being 10 g. and 
11 g./lOO ml. An adequate amount of blood 
was infused into both during or shortly 
after the operation to correct the anemia.
In summary, neither hypovolemia, nor 
electrolyte imbalance nor inadequate red 
cell mass could be considered important 
causes of death in this group of patients.
Pathological Findings at Operation
The presence and degree of peritonitis 
correlated best with the mortality. Table II 
shows that two of 14 patients found to 
have localized peritonitis at operation, and 
six of 12 with generalized peritonitis died. 
The peritonitis was directly or indirectly 
responsible for all these deaths except one 
where acute myocardial infarction was the 
cause of death. The underlying disease 
process causing bowel perforation and gen­
eralized peritonitis was carcinoma in four, 
diverticulitis in three, volvulus of the cecum 
in three, blunt abdominal trauma in one, 
and intussusception in one.
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TAB LE  II.—Mortality According to Intraperitoneal Pathology Found at Operation
Pathology No. of patients Deaths M ortality {%)
Simple obstruction............................................................... 12 1 8
Localized peritonitis............................................................ 14 2 14
Generalized peritonitis........................................................  12 6 50
Other.....................................................................................  5 l  20
T otal................................................................................................  43 io (23%)
Of the 43 patients undergoing emergency 
right hemicolectomy three (9%) developed 
anastomotic breakdown proved at autopsy. 
All three patients had generalized peritonitis 
at the time of operation. Another two pa­
tients were suspected of having disruption 
of their anastomosis. Both died of peritonitis 
but because they had peritonitis before 
operation and because no autopsy was per­
formed, the diagnosis of anastomotic failure 
is in doubt. By contrast, only nine of the 
206 patients (4%) submitted to elective 
resection of the right colon developed leaks 
at the anastomosis.
The primary colonic lesion had caused 
simple obstruction without peritonitis in 
12 patients. The only death in this group 
was from massive pulmonary embolism on 
the day of discharge from hospital.
Operative Technique
Neither the technique of anastomosis nor 
the use of peritoneal lavage could be con­
sidered important in determining the final 
outcome. All patients had a two-layer an­
astomosis and in none did the surgeon 
indicate in his operative report that poor 
blood supply or tension was present at 
the suture line. In 21 of the 33 survivors 
and in seven of the 10 patients who died 
the peritoneal cavity was lavaged with saline 
solution.
Use of Antibiotics
All but two patients received antibiotics 
postoperatively. Of the two who did not, 
one died. The most frequently used anti­
biotic was penicillin in combination with 
streptomycin or kanamycin. The data are 
insufficient to permit any firm conclusion. 
Nine of the 10 patients who died had 
adequate and appropriate antibiotic cover­
age.
Discussion
This study has shown that the presence 
and degree of peritonitis at the time of 
emergency right hemicolectomy with anas­
tomosis determine the outcome of the opera­
tion. Neither the patient’s age, nor the 
presence of associated diseases, nor pre- 
operatively uncorrected hypovolemia and 
electrolyte imbalance, nor any details of 
the operative technique, nor lack of sup­
portive antibiotic therapy could be regarded 
as important in explanation of the high 
mortality.
The detrimental effect of peritonitis on 
healing of intestinal anastomoses was ex­
perimentally shown by Letwin, Williams and 
Harrison.3 Their conclusions are in agree­
ment with our clinical observation that three, 
and possibly five, out of 12 patients who 
had generalized peritonitis at the time when 
resection and anastomosis were performed 
developed disruption of their anastomosis. 
Recently Niinikoski, Grislis and H unt6 have 
shown that infection reduces tissue collagen 
in wounds. The investigators have suggested 
the following possible reasons for this: 
(a) anoxia in the healing tissue, (b) action 
of bacterial collagenase, and (c) an im­
munologic process favouring release of ly­
sosomal proteolytic activity from phago­
cytes.
We have avoided primary anastomosis in 
emergency operations on the left colon 
done for reasons of obstruction or perfora­
tion. Under these circumstances we have 
resorted to staged management, employing 
colostomy with or without resection of the 
diseased bowel. The mortality at the Van­
couver General Hospital for such staged 
management of left colon emergencies has 
been 6 % .7 There is no good reason why 
we cannot achieve this relatively low mortal­
ity in obstructing, perforating, or gangrenous
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lesions of the right colon. This study has 
shown that right colon lesions causing 
simple obstruction without peritonitis can 
be safely treated by emergency resection 
with primary anastomosis. Our high mortal­
ity in emergency right hemicolectomy is 
largely owing to our decision to perform 
intestinal anastomosis in the face of peri­
tonitis.
We now believe that when a right colon 
lesion has caused peritonitis, it is best 
resected in order to eliminate continuing 
peritoneal contamination. Anastomosis, how­
ever, should be avoided in order to eliminate 
the danger of anastomotic breakdown. This 
treatment would therefore require the con­
struction of a temporary ileostomy and 
mucous fistula of the transverse colon. Re­
constitution of intestinal continuity is then 
achieved electively when peritonitis has been 
controlled. Better knowledge of fluid and 
electrolyte replacement has helped to reduce 
our fear of the “running ileostomy”.
Similar conclusions have been reached 
in the management of right colon injuries 
incurred in the Vietnam conflict: Chilimin- 
dris et al.8 recommend that small or multi­
ple wounds without mesenteric or other 
organ involvement, or without massive con­
tamination, be treated with a right colectomy 
and ileotransverse colostomy; whereas large 
wounds of the right colon with gross con­
tamination and injuries to other intra-abdo­
minal organs are better treated with a ma­
tured ileostomy and distal mucous fistula.
Su m m a r y
The operative mortality in 838 consecu­
tive patients undergoing colectomy with 
anastomosis was 4.9%. Of these resections, 
535 involved the left colon or rectosigmoid 
with 3% mortality. Right hemicolectomy 
had twice this mortality (6.4%). This un­
expectedly high mortality was largely owing 
to deaths after emergency right hemicolec­
tomy. Ten of 43 patients (23%) who under­
went emergency right hemicolectomy died.
This study was undertaken to search for 
the cause of the poor results in emergency 
right hemicolectomy. Neither the patient’s 
age, nor the presence of associated diseases, 
nor preoperatively uncorrected hypovolemia 
and electrolyte imbalance, nor any details 
of the operative technique, nor lack of 
supportive antibiotic therapy could explain 
the poor results. The presence and degree 
of peritonitis at the time of colectomy and 
anastomosis were the most important ex­
planation for the high mortality.
Our experience has led us to believe that 
emergency colectomy with anastomosis is 
a safe operation when a right colon lesion 
has caused simple obstruction. When the 
lesion has caused peritonitis, however, we 
believe that while resection of the diseased 
bowel is the surest way of eliminating con­
tinued peritoneal contamination, primary 
anastomosis should be avoided in order to 
avoid the dangers of anastomotic break­
down. This requires construction of a tem­
porary ileostomy and mucous fistula of the 
transverse colon, and a second-stage re­
constitution of intestinal continuity.
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B O O K  R E V I E W S
COSMETIC FACIAL SURGERY. Thomas D.
Rees and Donald Wood-Smith. 609 pp. Illust.
W. B. Saunders Company, Philadelphia;
W. B. Saunders Company Canada Limited,
Toronto, 1973. $56.65.
This is an impressive and richly bound book. 
It includes contributions by eight authors and 
is well illustrated by Daisy Stilwell with photo­
graphs by John Allan. The first chapter deals 
with the concepts of beauty and in richly 
coloured illustrations gives an account of vary­
ing standards of beauty throughout the world. 
These opening 16 pages are an overture to a 
good work, but their omission might have re­
duced materially the cost of the book to bring 
it within the means of more postgraduate 
students.
Succeeding chapters deal with the selection 
of patients and the preoperative exchange of 
information between surgeon and his patient. 
The guidelines are generally realistic and 
sound. The chapter on hypnosis, analgesia and 
anesthesia covers in a most cursory way 
anesthetic gases, drugs and complications. Its 
overriding message is to have a friend along 
in the operating room, namely an anesthetist, 
to look after the patient’s general condition 
while the surgeon concerns himself with the 
surgery. No one can quarrel with this philoso­
phy. The chapter on blepharoplasty comprises 
12 pages of text and includes the history and 
etiology of baggy eyelids, the operative tech­
nique and four pages of possible complications. 
The written text is complemented with 72 
pages of large, clear, excellent photographs 
and diagrams of surgical techniques. In the 
description of facelifts a little more than 50% 
of the text is devoted to postoperative care, 
complications and secondary rhytidectomy. The 
operative technique and preoperative and 
postoperative results are illustrated in a sec­
tion of 70 pages. The chapter on chemobrasion 
and dermabrasion provides an adequate dis­
cussion of techniques not universally accepted 
by plastic surgeons.
Rhinoplasty is clearly and fully described in 
226 pages. The anatomy and physiology of the 
nose are satisfactorily covered and there is 
a good section on airway resistances and air 
pressure flows. Each stage of the operative 
procedures is well illustrated and supported by 
clinical photographs in most cases. The book 
is justified by this chapter alone.
There are sections dealing with mentoplasty, 
prognathism, otoplasty and hair transplanta­
tion. These chapters are adequate, except the 
one on prognathism, which could be more 
complete.
In summary this is an excellent text on ble­
pharoplasty, facelift and rhinoplasty, and of­
fers satisfactory coverage of the other sub­
jects mentioned. The large print, clear illus­
trations and photographs, and excellent de­
scriptions of cosmetic facial surgery should 
recommend it to novice and expert alike.
W. R eid W aters
The Winnipeg Clinic,
Winnipeg, Man.
DISEASES OF THE VULVA. N ikolas A. 
Janovski and Charles P. D ouglas. 125 
pp. Illust. Harper & Row, P ublishers, 
Inc., New York. 1972. $17.50.
A textbook devoted to diseases of the  vulva 
has been a need long unfulfilled so th a t  th is  
volume will be eagerly welcomed by gyne­
cologists. I t  succeeds in being h ighly  com­
prehensive w ith in  the compass o f a slim 
fo rm at by adm irable conciseness of ex­
pression. In the  account of some conditions, 
notably p ru r itu s  vulvae, th is  com pression 
is of such degree as to d e trac t from  its  
p ractical usefulness. The illu stra tions, in 
general, are  of excellent quality. The om is­
sion of any m ention of m arsupialization  in 
the m anagem ent of bartholin  cysts is su r­
p rising , as is the recom m endation  th a t  
podophyllin be applied to vulvar w a rts  only 
in hospital. The d iffe ren tia tion  of k rau ro sis  
and leukoplakia, for so long an extrem ely 
vexed question, is em inently sensible. The 
fo rm er term  m eans shrinkage, th e  la tte r  
means white patches on the skin or mucosa. 
N e ith e r is a d iagnosis—they  a re  sim ply 
descriptive te rm s and it is the underly ing  
cause th a t m ust be sought and trea ted .
As a reference work to a ss is t in the 
identification  o f infrequently  seen and 
hence u n fam ilia r entities, th is  book will 
be invaluable to  the specialist.
A. W. Andison
FRACTURES AND DISLOCATIONS IN 
CHILDREN. Andrew G. Pollen. 233 pp. 
Illust.C hurchill Livingstone, Edinburgh; 
Longman Canada Limited, Toronto, 1973. 
$19.75.
A lthough orthopedic surgeons have accu­
m ulated vast clinical experience in  th e  prob­
lems of ped ia tric  patien ts, re la tively  few 
tex ts  a re  available which deal w ith  the 
orthopedic problem s of children, p a rtic u ­
larly  those due to traum a. This deficiency 
is successfully remedied by th is  excellent 
text, which rep resen ts the clinical experi­
ence and philosophy of its  au thor. He deals
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with the various problems according to 
their anatomical areas. The accounts of his 
personal approaches are educationally in­
structive.
The text would have been improved if the 
sections on pathological and epiphyseal 
fractures had given greater detail. Chapters 
that deserve outstanding praise are those 
on the elbow region, the forearm and wrist, 
and the battered baby syndrome. The book 
serves as an eminently practical guide for 
pediatricians and a useful manual for 
orthopedic surgeons.
The illustrations are of excellent quality 
and the bibliography is adequate.
This text can be read with enjoyment 
and is recommended to all concerned with 
the musculoskeletal problems associated 
with trauma in pediatric patients.
R. A. S ilver
D epartm ent of Orthopaedics,
U.S. Public Health Service Hospital,
Seattle, W ashington.
INTENSIVE CARE OF THE SURGICAL
PATIENT. Edited by Marshall D. Goldin.
500 pp. Illust. Year Book Medical Pub­
lishers, Inc., Chicago, 1971. Price not
stated.
This monograph written by over 40 authors 
is designed to outline the management of 
the surgical patient in the Intensive Care 
Unit. The first 86 pages are devoted to the 
principles involved in the management of 
any seriously ill patient, i.e. postoperative 
monitoring, central venous pressure, tra ­
cheostomy, etc. Chapters are devoted to 
renal failure, surgical infections and pa­
renteral intubation. The remainder of the 
monograph is devoted to special body sys­
tems. The chapters on thoracic surgery, 
cardiac surgery—pediatric and adult—are 
particularly well done. This work will serve 
a purpose as a readily available reference 
in all Intensive Care Units and will un­
doubtedly be useful to staff members, resi­
dents and nurses.
C. M. COUVES
D epartm ent of Surgery,
U niversity of Alberta Hospital,
Edmonton, Alta.
THE MANAGEMENT OF NEONATES 
AND INFANTS WITH CONGENITAL 
HEART DISEASE. Donal M. Billig and 
Marshall B. Kreidberg. 182 pp. Grune & 
Stratton, Inc., New York; Longman Ca­
nada Limited, Toronto, 1973. $14.75.
This fine monograph is essentially a com­
pact synopsis of current knowledge of the 
management of infants with congenital 
heart disease. After brief sections on patho­
physiology, diagnostic techniques, anesthe­
tic management and intraoperative and 
postoperative care, each of the more com­
mon congenital heart lesions is considered 
separately. Although concise and well w rit­
ten, the lack of illustrations may make it 
difficult for the student to follow. The 
material is up-to-date and well organized. 
Of particular value is a full, well-chosen 
list of references a t the end of each chapter.
Because it is brief this volume will be 
most useful to residents, nurses and students 
seeking a general knowledge of congenital 
heart disease and its management. I t  should 
also be of interest to cardiologists and other 
clinicians not ordinarily involved in caring 
for infants with congenital heart disease.
G. A. T rusler
D epartm ent of Surgery,
The H ospital fo r Sick Children,
Toronto, Ont.
NONOPERATIVE ASPECTS OF PEDIA­
TRIC SURGERY. With Special Emphasis
on Surgical Neonatology. Richard S. Owings.
146 pp. Illust. Warren H. Green, Inc., St.
Louis, 1973. $10.00.
The author states in the introduction that “it 
is imperative that the pediatrician, general 
practitioner and surgeon have readily at hand 
information regarding nonoperative aspects of 
care for the pediatric surgical patient”. Draw­
ing upon his training and experience, which 
seems quite extensive, he sets out his thoughts 
and relates the facts on a number of topics 
common to the management of pediatric sur­
gical problems in a simple, readable fashion 
(the aim he states in his introduction), but 
really adds nothing that is not already covered 
in other texts on the same subjects. Pediatri­
cians, general practitioners and surgeons deal­
ing with such problems probably will not bene­
fit more from this book than from larger 
texts. However, I must admit that as a prac­
tising pediatric surgeon, I enjoyed the book 
since it exposed me to the thoughts and prac­
tices of another pediatric surgeon; in this 
context the work has some merit.
S. H. E in
The Hospital for Sick Children,
Toronto, Ont.
RADIOLOGICAL DIAGNOSIS OF DI­
GESTIVE TRACT DISORDERS IN THE 
NEWBORN. A Guide to Radiologists,
(Continued on Adv. page 35)
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Surgeons and Paediatricians. B. J. Cre- 
min, S. Cywes and J. H. Louw. 146 pp. 
Illust. Butterworth & Co. (Canada) Ltd., 
Toronto; Butterworth & Co. (Publish­
ers) Ltd., London, 1973. $22.35.
This small book describes the radiologic 
diagnosis of lesions of the esophagus, sto­
mach, duodenum, small and large intestines 
and anorectal region in newborn infants 
and contains an additional chapter on plain 
films of the abdomen. For each lesion the 
authors discuss the pathology and patho­
genesis, clinical presentation and radiologic 
findings on both plain films and contrast 
studies.
The writing is well organized, clear and 
concise. The information is, in general, 
accurate and complete although there are a 
few weak areas. In the brief section on 
vascular rings, for instance, the authors 
rather overemphasize the symptoms attri­
butable to these lesions and suggest that 
anomalous origin of the innominate or left 
carotid arteries can cause stridor, which is 
rather doubtful. However, most of the dis­
cussions are excellent, especially in those 
subjects in which the authors have a parti­
cular interest, such as Hirschsprung’s di­
sease and anorectal malformations. They 
mention a new and, they believe, more accu­
rate landmark for the puborectalis muscle 
on lateral films of the pelvis. The plain 
film x-ray findings are well described as 
are the methods and results of contrast 
studies. They give some useful hints about 
doing these procedures and emphasize the 
value of videotape recording. I believe they 
should have been more explicit in discussing 
the dangers of fluid and electrolyte im­
balance in using Gastrografin in newborn 
infants and the precautions that should be 
taken.
Unfortunately the references in most of 
the chapters are very limited and are often 
to surgical textbooks. More references to 
some of the current radiologic literature 
would be useful.
The radiographs in the first five chapters 
are poorly reproduced and although most 
of them manage to show what is intended, 
some do not. However, the illustrations in 
the last chapter are excellent and demon­
strate some beautiful radiologic studies of 
anorectal malformations.
Overall, this is an excellent book. I highly 
recommend it to any surgeon, pediatrician 
or radiologist as an up-to-date and readable
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account of the radiologic diagnosis of di­
gestive tract disorders in newborn infants.
M. H. Reed
Children’s Hospital of Winnipeg,
University of Manitoba,
Winnipeg, Man.
READINGS IN MODERN SURGERY. 
Edited by Richard H. Egdahl and John 
A. Manniek. 670 pp. Illust. Grune & 
Stratton, Inc., New York; Longman 
Canada Limited, Toronto, 1973. $24.75.
The authors intend this book to be a com­
panion volume to their “ Core Textbook of 
Surgery” . The book consists of reproduc­
tion of what the authors consider to be 
the best new articles dealing with those 
areas of clinical surgery in which there 
has been recent change since the publication 
of their 1970 anthology “ Modern Surgery” . 
Some 58 papers have been culled from the 
American surgical literature, mostly from 
the years 1969 to 1971 inclusive. The sub­
jects are from 24 fields as diverse as ar­
teries, endocrine glands, head and neck, 
heart, infections, liver, lungs, shock, sto­
mach, transplantation and tumours. Each 
article is followed by an overview of the
UNIVERSITY OF TORONTO 
Faculty of Medicine 
Division of
Postgraduate Medical Education
will offer
THE FOURTEENTH 
ANNUAL POSTGRADUATE 
REFRESHER COURSE 
FOR GENERAL SURGEONS.
February 4, 5, 6, 1974
Mount Sinai Hospital 
Toronto
Registration Fee — $90.00
For Information:
The Director,
Division of
Postgraduate Medical Education, 
Medical Sciences Building, 
UNIVERSITY OF TORONTO, 
Toronto, Ontario M5S 1A8.
subject and by an annotated bibliography.
Though most of the articles are good 
ones, the book cannot be recommended. The 
articles are all from two to four or more 
years old, and in any case are all available 
in any surgical library. They have been 
produced by a photoreduction technique that 
in many instances results in small, slightly 
fuzzy type that is inconvenient to read. 
Finally most of the overview comments are 
by the authors of the original papers, and 
merely repeat what was said in the articles.
J. E. Devitt
Continuing Medical Education,
Ottawa Civic Hospital,
Ottawa, Ont.
A SHORT TEXTBOOK OF SURGERY. 
9th ed. Sir Charles Illingworth. 307 pp. 
Illust. Churchill Livingstone, Edin­
burgh; Longman Canada Limited, To­
ronto, 1972. $18.00.
The author with the assistance of nine 
associates, all chairmen of surgical depart­
ments, has completely rewritten this short 
textbook of surgery. All of surgery (not in­
cluding gynecology) is covered in a uniform, 
easily readable style with useful illustra-
University of Toronto
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tions and an attractive format. Many useful 
references are provided for further reading, 
though unfortunately almost all of them 
are from United Kingdom publications.
The book admirably succeeds in its objec­
tive of being short and yet reasonably 
comprehensive in scope. But well written 
as it is, only so much information can be 
put into 298 pages of text which include 
253 illustrations. As a result the book would 
serve as an excellent introduction to surgery 
for undergraduate students. For this pur­
pose it is highly recommended. It is hoped 
that postgraduate students would have 
mastered this level and so should require 
a text of greater depth.
J. E. Devitt
Continuing Medical Education,
Ottawa Civic Hospital,
Ottawa, Ont.
SURGERY OF REPAIR AS APPLIED TO
H AN D  INJURIES. 4th ed. B. K. Rank,
A. R. Wakefield and J. T. Hueston. 390 pp.
Illust. Churchill Livingstone, Edinburgh;
Longman Canada Limited, Toronto, 1973.
$ 14.50.
The most recent edition o f this work follows 
the same approach as previous ones. The sub­
ject is dealt with in a systematic and logical 
way. Anatomy and diagnosis are presented 
first; treatment is divided into primary, inter­
mediate and secondary phases. Separate sec­
tions are devoted to burns o f the hand, hand 
injuries in children and prostheses.
Most changes introduced are minor but a 
few are important. For example, a new “ law” 
is advanced regarding the sensory innervation 
of the hand, viz. “ areas o f functional contact 
share a common nerve supply” .
A section on delayed primary closure has 
been added, an aspect o f management that has 
not been properly emphasized in the past. 
For the first time the use o f silicone rods to 
form new tendon sheaths is covered.
The section on the burned hand has been 
up-dated. The old method of classifying burns 
in degrees has been supplanted by a  more prac­
tical classification into superficial and deep 
burns. Electrical burns have also been reclas­
sified as domestic and industrial types.
The final chapter, “ The Aftermath of Hand 
Injuries” , is also new. This deals with the 
assessment o f disability, the objective result, the 
subjective result, and some points regarding 
legal aspects and the assessment o f damages.
It is disappointing that injuries o f the major 
blood vessels are not included since they are 
frequently encountered in wrist lacerations.
The text is well illustrated by a large num­
ber o f good photographs and line drawings, 
and is easy to read. The authors have also been 
able to keep the book to a comfortable size.
This book should be part o f the armamen­
tarium o f every surgeon dealing with hand 
injuries.
L eith  G . D ouglas
Department of Surgery,
The Wellesley Hospital,
Toronto, Ont.
SURGICAL LUNG DISEASES IN CHILD­
HOOD. W. Poradowska, S. Reszke and 
S. Kubicz. 292 pp. Illust. Polish Medical 
Publishers, Warsaw; National Library 
of Medicine, Bethesda, Md., 1972. $6.75.
This text from the Research Institute for 
Mother and Child in Warsaw, Poland con­
sists primarily of a compilation of material 
which is available in other texts and jour­
nals. It is, however, well organized and 
complete and covers a broad spectrum of 
congenital malformations and acquired di­
seases of the lungs and deals in some detail 
with their presentation and management. 
The text is succinct and concise. It is doubt­
ful whether this would be of interest to 
those in the general stream of pediatrics 
or pediatric surgery but it would be of 
particular interest to a specialist in thoracic 
disease and to radiologists. It is discon­
certing that the radiographs are published 
as positives but this is a minor complaint. 
The unusually low price of the text is ex­
ceedingly appealing and certainly puts the 
volume within the reach o f all who practise 
medicine. It is incredible that a text con­
taining several hundred illustrations and 
which is so well printed can be turned out 
at such a nominal cost— North American 
publishers take note!
These reviewers recommend it without 
reservation to those radiologists and pedia­
tricians— specialists or otherwise— who 
are interested in the pulmonary diseases, 
particularly those requiring surgical inter­
vention. We recommend it not only to this 
group but would like to see it in medical 
and hospital libraries as a reference text 
in its field for residents and interns.
R. B. Ly n n
E. J. P. Charrette
R. W igle
Etherington Hall,
Queen’s University,
Kingston, Ont.
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